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Abstract 
Repeated exposure to drugs of abuse alters the structure and function of neural 
circuits mediating reward, generating maladaptive plasticity in circuits critical for 
motivated behavior. Within mesocorticolimbic dopamine circuitry, repeated exposure to 
cocaine induces progressive alterations in AMPAR-mediated glutamatergic synaptic 
transmission. During abstinence from cocaine treatment, AMPAR signaling is potentiated 
at synapses on nucleus accumbens (NAc) medium spiny neurons (MSNs), promoting a 
state of heightened synaptic excitability. Re-exposure to cocaine during abstinence, 
however, reverses and depotentiates enhanced AMPAR signaling, demonstrating that 
cocaine bidirectionally alters excitatory synaptic transmission in the NAc. Understanding 
the neurobiological mechanisms underlying drug-induced synaptic adaptations in the 
NAc could provide targets for developing strategies to reverse or offset maladaptive 
processes driving long-lasting vulnerability to relapse. However, the detailed cellular 
signaling mechanisms mediating cocaine-evoked plasticity have not been well-
characterized. Using pharmacological approaches in combination with patch-clamp 
recordings in the NAc, we investigated the role of candidate signaling factors that 
mediate adaptive synaptic plasticity in the striatum. Among these, activation of group I 
metabotropic receptors (mGluR1/5) play a prominent role in synaptic depression at 
excitatory synapses, and furthermore are implicated in models of relapse to drug-seeking. 
Consistent with this, we found that activation of mGluR5 is necessary for cocaine-
induced depotentiation of AMPAR signaling in the NAc. Downstream of mGluR1/5 
receptors, mobilization of endogenous cannabinoids (eCBs) is an important factor 
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modulating excitatory synaptic strength. Dopamine receptors in the striatum also broadly 
modulate synaptic transmission at glutamatergic terminals on MSNs, and are critically 
engaged by drugs of abuse. Both dopamine and eCB signaling were necessary factors in 
the induction of cocaine-induced synaptic plasticity in the NAc, suggesting that these 
neuromodulators may modify the responsiveness of MSNs to alterations in glutamatergic 
input induced by cocaine. Finally, we examined plasticity at synapses on specific MSN 
cell subpopulations, demonstrating that specific dopamine receptors on distinct cell types 
promote specific modifications in AMPAR synaptic function following cocaine 
experience. These neuromodulatory signaling mechanisms may serve to gate the 
induction of plasticity at glutamatergic afferents on NAc MSNs by converging on 
common factors that control the sensitivity of MSNs to excitatory input, ultimately 
driving addiction-related behavior. 
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Introduction and background 
 
Drug addiction is a major public health problem in the US, affecting an estimated 
8-10% of adult Americans (SAMHSA, 2015). Up to 4% of the US adult population has 
abused illicit psychostimulant drugs including cocaine and methamphetamine in 2015, 
with 900,000 of these individuals being diagnosed with a substance use disorder 
(SAMHSA, 2015). While the current opioid abuse epidemic might suggest that abuse of 
other substances including psychostimulants is a less urgent issue, national data on 
overdose deaths during 2010-2014 indicates that the age-adjusted rate of drug overdoses 
involving psychostimulants has more than doubled during the last five years (Warner et 
al., 2016). Each year, cocaine consistently ranked second or third among drugs involved 
in overdose deaths. Furthermore, cocaine use was a common factor in overdoses 
involving multiple drugs, which described nearly half (48%) of all overdose deaths 
during 2010-2014. These recent findings provide evidence that psychostimulant addiction 
remains a major issue in the US. Effective therapies for addiction assist individuals in 
achieving enduring relief from relapse. However, while several pharmacological 
therapies have been FDA-approved for treating opioid abuse, none currently exist for 
psychostimulant addiction. Developing effective treatments for addiction requires 
understanding the neurobiological mechanisms underpinning drug seeking behavior and 
the complex physiological, cognitive, and motivational aspects of addiction.  
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Synaptic plasticity and addiction 
Over the past several decades, an extensive body of research has demonstrated 
that alterations in neural circuitry critical for reward-related learning, motivation, and 
cognition underlie key features of drug addiction (Hyman et al., 2006; Thomas et al., 
2008; Volkow and Morales, 2015). These circuits naturally permit organisms to learn 
about their environments and adapt to important stimuli, including whether to approach 
sources of food or sex, or to avoid harmful situations (Everitt and Robbins, 2005). In drug 
addiction, neural circuitry important for reward and reinforcement undergo 
neuroplasticity that develops as a consequence of repeated drug experience. Over time, 
modifications in cells, circuits, and systems impair the selection of adaptive behavioral 
stimuli in favor of progressively-increasing drug-seeking and drug-taking strategies 
(Kalivas and Volkow, 2005). These strategies manifest clinically as persistent and 
recurrent drug-seeking behavior at the expense of pursuit of natural rewards (Kalivas and 
O’Brien, 2007). The chronic, relapsing nature of addiction is today generally accepted by 
the medical and scientific communities to reflect aberrant resculpting of motivational 
circuitry that drives drug-seeking, preventing lasting abstinence. However, few effective 
treatment options exist. Successful therapeutic strategies for treating drug addiction must 
assist individuals in maintaining abstinence, providing relief from the cycle of 
intoxication, abstinence, and craving that leads to relapse (Koob and Volkow, 2009). To 
do so will require understanding the drug-induced neurobiological alterations in brain 
function that undergird long-lasting vulnerability to relapse.  
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The nucleus accumbens: structure, function, and role in addiction 
 The nucleus accumbens (NAc) is a structure within the ventral striatum and a 
critical component of dopaminergic mesocorticolimbic circuitry governing reward-
related learning, motivation, and cognition. The NAc receives dense dopaminergic 
projections from the midbrain in addition to extensive glutamatergic innervations from 
cortical, limbic, and thalamic areas. GABAergic medium spiny neurons (MSNs), which 
comprise over 95% of the total neuronal population in the NAc, project to structures 
mediating motor behavior. Thus, the NAc acts as an interface integrating cortical and 
limbic information and is thus critically positioned to regulate motivated behavior and 
learning (Groenewegen et al., 1999). MSNs within the NAc can be further distinguished 
by the expression of the dopamine receptor 1 subtype (D1-MSN) or receptor 2 subtype 
(D2-MSN), with a small percentage expressing both types. These distinct MSN 
subpopulations have divergent projection targets and have distinct roles in addiction-
related behavior (Lobo and Nestler, 2011).  
 The NAc is composed of two distinct subdivisions: core and shell. Each of these 
regions has been shown to possess distinct functions, circuitry, and signaling mechanisms 
(Voorn et al., 2004). The core region is well-connected to motor circuitry and is generally 
thought to play a major part in initializing reward-related motor activities, controlling the 
acquisition of drug-seeking behavior. The shell is more heavily innervated by cortical and 
limbic regions, and is thus essentially involved in motivation and reward-related 
processes, including motivation to seek drugs.  
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 Extensive experimental evidence indicates that the NAc is a crucial locus for 
drug-induced plasticity and mediates many complex behavioral and motivational aspects 
of addiction (Kauer and Malenka, 2007; Lüscher and Malenka, 2011). While augmented 
dopaminergic release from the ventral tegmental area (VTA) induced by drugs of abuse 
drives early behavioral responses to addicting drugs (Kauer and Malenka, 2007), 
alterations in NAc glutamatergic synaptic transmission that develop as a consequence of 
repeated, long-term drug experience have been well-demonstrated to underlie the 
persistence of drug-seeking behavior (Wolf, 2016), likely representing the strength of 
reward-related associative learning about drug experiences. In preclinical studies of 
addiction, activity and plasticity at glutamatergic afferents on NAc MSNs critically 
regulate the rewarding and reinforcing effects of drugs, rendering the NAc a prime target 
for investigating how experience with drugs of abuse alters brain function and drives 
persistent vulnerability to relapse. 
 
Animal behavioral models of drug addiction 
Behavioral sensitization 
 Repeated administration of a psychostimulant drug produces progressive 
increases in the locomotor-activating properties of the drug, a phenomenon known as 
behavioral sensitization. Produced by repeated experimenter-administered drug 
injections, the development of sensitization is associated with a number of behavioral and 
neurobiological adaptations within mesocorticolimbic dopamine circuitry implicated in 
addiction (Vanderschuren and Pierce, 2010), and therefore may be used as an index of 
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drug-related adaptations in reward circuit function. Sensitized animals acquire drug self-
administration more easily (Piazza et al., 1989) and work harder under progressive ratio 
schedules of reinforcement to obtain drug (Lorrain et al., 2000; Mendrek et al., 1998), 
demonstrating that mechanisms of plasticity underlying behavioral sensitization might 
overlap with motivational processes in the brain that mediate drug-seeking behavior. 
Furthermore, sensitization is a long-lasting behavioral adaptation (Paulson et al., 1991), 
suggesting that neurobiological alterations underlying this phenomenon might play a role 
in persistent vulnerability to relapse. 
 
Self-administration models 
 Drug self-administration procedures are dependent (“contingent”) on an animal’s 
response, providing a useful model for assessing the reinforcing and motivational 
properties of a drug (Shaham et al., 2003). To model human conditions in which drug-
taking is periodically terminated due to the negative consequences of addiction, animals 
may be placed in forced abstinence following the acquisition of drug self-administration. 
Alternatively, extinction training is used to extinguish behavioral responding to the 
availability of a drug. The renewal, or reinstatement, of drug seeking behavior may be 
elicited by presenting the animal with cues associated with previous drug use, a stressor, 
or drug re-exposure—potent triggers that precipitate relapse in humans. Thus, self-
administration models provide a relevant means of studying drug-induced plasticity 
associated with relapse to drug-seeking behavior. 
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Glutamatergic synaptic plasticity in cocaine addiction: role of AMPA receptors 
 In the absence of glutamatergic input, the MSN membrane potential naturally 
resides in a hyperpolarized state (-80 mV), rendering these cells normally quiescent. 
However, strong coincident glutamatergic input from afferents impinging on MSNs can 
cause a transition from low to high activity due to activation of post-synaptic glutamate 
receptors that depolarize neurons to spike thresholds (Surmeier et al., 2007). Striatal 
circuits therefore rely on strong glutamatergic afferent input to drive their activity. 
Glutamate inputs activate MSNs in the NAc predominantly by acting at ionotropic 
AMPA-type glutamate receptors (AMPARs) (Hu and White, 1996; Pennartz et al., 1990), 
which mediate the majority of excitatory synaptic transmission in the brain. Structurally, 
AMPARs are tetramers consisting of GluA1-4 subunits typically organized as dimers of 
dimers. Within the NAc, the majority of AMPARs consist of GluA1/2, with a smaller 
population lacking the GluA2 subunit and therefore existing as either homomeric GluA1 
or GluA1/3 (Reimers et al., 2011; Wenthold et al., 1996). GluA2-lacking receptors allow 
higher channel conductance, are permeable to calcium, and display inward rectification 
due to voltage-dependent modulation by intracellular polyamines, thus having robust 
effects on synaptic plasticity that are distinct from GluA2-containing receptor 
compositions (Thiagarajan et al., 2007).  
 Multiple lines of evidence indicate that experience-dependent alterations in 
glutamate transmission in the NAc, such as those produced by repeated exposure to 
cocaine, involve alterations in post-synaptic signaling mediated by AMPA-type receptors 
(Pierce and Wolf, 2013; Wolf and Ferrario, 2010). Early studies found that AMPAR 
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activation in the NAc is necessary for drug seeking in a number of animal models 
(Conrad et al., 2008; Cornish et al., 1999; Suto et al., 2004). Upregulation of AMPAR 
signaling at excitatory synapses on NAc MSNs may strengthen drug-related associations 
over long periods of time and drive robust behavioral responding to drug re-exposure or 
cues associated with drugs. Consistent with this, repeated cocaine exposure produces a 
progressive increase in MSN AMPAR signaling during abstinence that heightens the 
sensitivity of MSNs to glutamatergic input, and is a key factor in the development and 
persistence of addiction-related behavior such as behavioral sensitization, craving, and 
relapse (Wolf and Ferrario, 2010).  Cell surface expression of GluA1 AMPAR subunits is 
increased in the NAc during mid-late abstinence (Day 7-45), but is not present 
immediately after the last cocaine exposure (Day 1) (Boudreau and Wolf, 2005; 
Boudreau et al., 2007; Conrad et al., 2008; Ferrario et al., 2011; Ghasemzadeh et al., 
2009), indicating that accumulation of synaptic AMPARs following cocaine treatment 
requires time to develop. Additionally, electrophysiology studies reveal that AMPAR 
signaling is potentiated in the NAc shell in late abstinence (Day 10-45), again with no 
effect observed in early abstinence (Conrad et al., 2008; Kourrich and Thomas, 2009; 
Pascoli et al., 2014, 2011; Terrier et al., 2016).  
In contrast, during abstinence from cocaine, exposure to a cocaine challenge 
injection reverses, or “depotentiates,” cocaine-dependent increases in NAc shell AMPAR 
signaling, promoting a reduction in glutamate sensitivity of MSNs. Within 24 hours 
following cocaine challenge, cell surface expression of GluA1 and GluA2 is reduced 
(Boudreau et al., 2007; Ferrario et al., 2009), and excitatory synaptic currents are 
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attenuated (Kourrich et al., 2007). Furthermore, exposure to stress is similarly capable of 
inducing synaptic depotentiation in NAc MSNs (Rothwell et al., 2011), demonstrating 
that both drug re-exposure and stress, common triggers for evoking relapse, promote 
similar reductions in NAc excitatory synaptic strength. Synaptic adaptations associated 
with relapse-inducing stimuli could provide a neurobiological correlate for understanding 
the processes that underlie vulnerability to relapse. Alterations in AMPAR-mediated 
synaptic strength in the NAc may therefore drive renewed drug-seeking behavior during 
withdrawal. However, the mechanisms underlying bidirectional alterations in AMPAR 
synaptic transmission in the NAc have not been well defined. 
One possibility is that re-exposure to cocaine or other relapse-associated stimuli 
promotes removal of AMPARs from the membrane, yielding a reduction in synaptic 
strength. Indeed, a common mechanism throughout the brain for altering glutamatergic 
synaptic strength involves regulating the trafficking of AMPARs into and out of the 
synapse on a rapid timescale (Derkach et al., 2007; Shepherd and Bear, 2011). Several 
lines of evidence indicate that AMPAR trafficking mechanisms play a role in cocaine-
induced alterations in glutamatergic synaptic strength in the NAc. Several studies found 
that cell surface expression of GluA1 and GluA2 AMPAR subunits is decreased 24 hours 
after a cocaine challenge (Boudreau et al., 2007; Ferrario et al., 2011), indicating that 
AMPARs are internalized following cocaine re-exposure. Additionally, blocking 
endocytosis of AMPARs with a synthetic peptide prevents the expression of 
amphetamine sensitization and the induction of long-term depression at NAc MSN 
synapses (Brebner et al., 2005), demonstrating a critical role for AMPAR trafficking in 
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drug-related behavior and synaptic plasticity. Regulation of AMPAR trafficking 
mechanisms may therefore mediate the reversal of potentiated AMPAR signaling induced 
by repeated cocaine, suggesting a process through which synapses rapidly adapt to drug 
re-exposure.  
 
Ex vivo cocaine: a model for understanding drug re-exposure-induced plasticity 
 Understanding the detailed cellular and temporal mechanisms of cocaine-induced 
synaptic plasticity requires isolating specific candidate signaling mechanisms. To 
investigate the specific mechanisms of AMPAR synaptic depotentiation in the NAc 
induced by cocaine re-exposure, we developed an ex vivo drug challenge model that 
allows us to pharmacologically target and manipulate specific signaling factors necessary 
for cocaine-induced plasticity. This approach could allow for resolving specific 
mechanisms as well as temporal parameters of NAc synaptic plasticity—fine details that 
are difficult to assess in in vivo models. The goal of this model is to provide a screening 
tool to identify candidate mechanisms of plasticity that might guide future investigations 
of drug-related synaptic plasticity. 
 In this model, animals undergo repeated injections of cocaine that produce robust 
behavioral sensitization. Identical to in vivo sensitization studies from our lab (Kourrich 
et al., 2007), animals are then placed in abstinence for 10-14 days. Following the 
abstinence period, however, instead of an in vivo challenge injection, the cocaine re-
exposure is carried out by perfusing slices from pre-treated animals in an artificial 
cerebrospinal fluid (ACSF) solution containing 10 µM cocaine. This concentration of 
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cocaine was chosen since it has been shown to promote plasticity in acute slice 
preparations without causing local anesthetic effects (Brodie and Dunwiddie, 1990; 
Schilström et al., 2006). Slices are exposed to ex vivo cocaine for a discrete time period 
(10 min), modeling in vivo cocaine re-exposure. 
 In a recent study (Jedynak et al., 2016), we sought to validate this model by 
testing whether ex vivo cocaine produces bidirectional AMPAR-mediated plasticity in the 
NAc, similar to plasticity our lab has observed following in vivo (Kourrich et al., 2007). 
Mirroring in vivo cocaine drug re-exposure, incubation of acute slices in cocaine reversed 
the potentiation of AMPAR-mediated synaptic transmission in the NAc shell and core, 
demonstrating that ex vivo cocaine can bidirectionally modulate excitatory synaptic 
transmission in the NAc. We additionally found that ex vivo amphetamine is similarly 
capable of depotentiating enhanced AMPAR transmission during abstinence, again 
reflecting in vivo amphetamine data from our lab (Jedynak et al. 2016). Interestingly, we 
furthermore observed that the region-specific effects (i.e. NAc core vs. shell) of in vivo 
cocaine and amphetamine on AMPAR plasticity once again held true in the ex vivo 
model, with cocaine exerting effects in both shell and core while amphetamine 
preferentially altered AMPAR transmission in the shell only. Given these striking 
similarities between the ability of in vivo and ex vivo psychostimulant exposure to 
bidirectionally alter glutamatergic transmission in the NAc, this model appears to be a 
highly viable and useful approach for probing cellular signaling mechanisms of synaptic 
plasticity. 
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Purpose  
 In summary, AMPA receptors mediate critical alterations in glutamatergic 
synaptic plasticity in the NAc evoked by cocaine. Our lab and others have observed that 
while AMPAR signaling is potentiated during abstinence from cocaine, a single re-
exposure to cocaine or cues associated with drug use is sufficient to reverse this 
plasticity, inducing synaptic depotentiation. This synaptic adaptation elicited by common 
triggers for relapse in humans might represent a neurobiological correlate for studying 
relapse vulnerability in the brain. However, the cellular mechanisms underpinning this 
plasticity have not been characterized. 
 In the following chapters, my purpose is to begin to characterize cellular signaling 
mechanisms important for cocaine-induced bidirectional plasticity in the NAc. Drawing 
from an expanding literature on endogenous mechanisms of plasticity commonly engaged 
by drugs of abuse, I describe the roles of a number of signaling mechanisms in cocaine-
evoked bidirectional plasticity: 
1. Characterize the role of the mGluR5 receptor and protein synthesis in 
bidirectional AMPAR plasticity in the NAc, comparing core and shell regions. 
2. Resolve the temporal dynamics of cocaine-induced plasticity, including onset and 
duration of AMPAR plasticity. 
3. Examine the role of the neuromodulators dopamine and endocannabinoids in NAc 
glutamatergic plasticity. 
4. Characterize cocaine-induced synaptic depotentiation involving specific 
dopamine receptor sub-types on specific MSN cell populations. 
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Chapter 1: Activation of mGluR5 and protein synthesis in the NAc are necessary for 
AMPAR depotentiation evoked by cocaine re-exposure 
  
Introduction 
Group I mGluRs: role in striatal synaptic plasticity 
 Metabotropic glutamate receptors (mGluRs) are G-protein coupled receptors 
(GPCRs) highly expressed at excitatory synapses throughout the brain that critically 
modulate glutamatergic synaptic activity and plasticity. Group I mGluRs comprise 
mGluR1 and mGluR5, Gq-coupled receptors that promote cleavage of the membrane 
phospholipid PIP2 through activation of PLC, generating DAG and IP3 that mobilize 
internal calcium stores, increasing the post-synaptic intercellular concentration of 
calcium. Augmented calcium levels activate a host of downstream cellular effectors and 
targets that modify glutamatergic synaptic transmission. Located outside of the active 
zone within peri-synaptic regions (Luján et al., 1996), mGluR1/5 are well positioned to 
modulate the activity of nearby ionotropic receptors.  
 In the striatum, glutamatergic synapses on MSNs are capable of expressing 
synaptic depression through several mechanisms. An extensive body of evidence has 
demonstrated that group I mGluRs mediate a prominent form of striatal long-term 
depression (mGluR-LTD) at excitatory synapses (Lüscher and Huber, 2010). Classic 
studies characterizing mGluR-LTD in the striatum identified that pharmacological 
activation of mGluR1/5 or high-frequency stimulation (HFS) is sufficient to induce 
synaptic depression at MSN synapses (Bellone et al., 2008; Gladding et al., 2009; 
Gubellini et al., 2004). Activation of post-synaptic mGluR1/5 initiates a cascade of 
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intercellular signaling mechanisms that participate in reducing excitatory synaptic 
strength through a number of pathways. In the nucleus accumbens (NAc), mGluR1/5 
activation promotes a long-lasting reduction in glutamate release probability (Robbe et 
al., 2002) coupled with internalization of AMPARs from the post-synaptic membrane 
(Mangiavacchi and Wolf, 2004; McCutcheon et al., 2011). NAc mGluR1/5 signaling thus 
regulates the activity of striatal circuits by dampening excitatory input to MSNs while 
reducing the responsiveness of neurons to glutamate. 
 
Group I mGluRs in cocaine-seeking behavior and plasticity 
 Group I mGluR receptors have been demonstrated to critically mediate addiction-
related behavior. In particular, the role of mGluR5 in cocaine-seeking behavior and 
synaptic plasticity in the NAc has been well-characterized. Transgenic mice lacking 
mGluR5 receptors do not develop behavioral sensitization to cocaine, and furthermore do 
not acquire cocaine self-administration behavior (Chiamulera et al., 2001). Intra-NAc 
administration of an mGluR5 antagonist attenuates cocaine-primed and cue-primed 
reinstatement of cocaine seeking behavior in the NAc core (Wang et al., 2013) and shell 
(Kumaresan et al., 2009). Consistent with this, stimulation of mGluR5 receptors in the 
NAc core (Wang et al., 2013) and shell (Schmidt et al., 2013) promotes cue- and cocaine-
primed reinstatement of seeking behavior. These findings indicate that mGluR5 signaling 
in the NAc shell and core plays a crucial role in cocaine-seeking behavior. However, the 
contribution of mGluR5 to cocaine-induced synaptic plasticity in the NAc has not been 
fully defined. Given the known role of group I mGluRs in regulating excitatory synaptic 
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transmission in the NAc (Robbe et al., 2002), activation of NAc mGluR5 following 
abstinence or extinction from cocaine might promote dampening of synapses potentiated 
by previous cocaine experience, representing a potential strategy for reducing cocaine 
craving and seeking behavior. Consistent with this, one study found that activation of 
group I mGluRs in the NAc following prolonged abstinence (>45 d) from cocaine self-
administration eliminates high-conductance calcium-permeable AMPARs from the 
synapse, reducing glutamatergic transmission (McCutcheon et al., 2011).  Previous 
studies have indicated that a reduction in elevated AMPAR synaptic transmission 
following cocaine exposure requires mGluR5 signaling mechanisms that promote 
phosphorylation and rapid endocytosis of AMPARs (Collingridge et al., 2004). For 
example, one report found that in addition to mGluR5, cocaine-primed reinstatement of 
seeking requires activation of PLCγ and PICK1, two cellular effectors activated 
downstream of mGluR5 that cooperate to initiate endocytosis of AMPARs (Schmidt et 
al., 2013). Given that re-exposure to cocaine enhances glutamatergic tone in the NAc 
(Kalivas, 2009; Knackstedt and Kalivas, 2009), subsequent engagement of mGluR5s on 
MSNs could function to dampen potentiated glutamatergic synaptic transmission through 
mGluR5-mediated internalization of AMPARs. 
 
Facilitation of synaptic plasticity by protein synthesis 
 A common requirement for mGluR1/5-mediated plasticity throughout the brain 
involves rapid protein synthesis (Lüscher and Huber, 2010). Stimulation of mGluR1/5 
promotes local synthesis of several LTD-associated proteins that participate in regulating 
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AMPAR trafficking and endocytosis at the synapse (Huber et al., 2000). For example, 
induction of mGluR5-LTD and AMPAR endocytosis requires rapid dendritic synthesis of 
Arc protein, which functions to couple changes in neuronal activity to rapid synaptic 
plasticity by regulating AMPAR endocytosis and inducing synaptic depression 
(Chowdhury et al., 2006; Shepherd and Bear, 2011; Waung et al., 2008). mGluR1/5 
activation therefore stimulates a number of proteins including Arc that negatively 
regulate AMPAR cell surface expression. Importantly, synthesis of these proteins is 
engaged by changes in neuronal activity associated with addiction-related behavior: a 
mechanism requiring rapid protein synthesis is required for sustained calcium-permeable 
AMPAR transmission in the NAc during incubation of cocaine craving (Scheyer et al., 
2014), and protein synthesis is similarly necessary for cue-evoked reinstatement of 
cocaine seeking (Smith et al., 2014). Thus, rapid protein synthesis in the NAc may be an 
important factor mediating depotentiation of enhanced AMPAR transmission during 
abstinence from cocaine. 
 The purpose of this study was to investigate the role of mGluR5 and protein 
synthesis in cocaine-induced depotentiation of AMPAR synaptic strength in the NAc. 
Furthermore, we examined the region-specificity of this plasticity by comparing 
mechanisms in both the NAc shell and core.   
  
Materials and methods 
Animals   
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Adult male (P49-70) C57BL/6 mice (Jackson Laboratories, Bar Harbor, Maine, 
USA) were used. All animals were group-housed in a temperature- and humidity-
controlled environment on a 12 hr light/12 hr dark cycle, with food and water available 
ad libitum. All experiments were approved by the Institutional Animal Care and Use 
Committee at the University of Minnesota. 
 
Behavioral sensitization 
Prior to testing, mice were habituated to experimenter handling, i.p. injections, 
and the testing environment (individual activity boxes, 8.5 x 17.5 x 9 in) over two days. 
On five consecutive testing days, mice were habituated to the testing environment for 30 
min before receiving an intraperitoneal injection of either cocaine (15 mg/kg) or saline. 
Mice were immediately placed back into the testing environment, and their activity was 
monitored for 90 min using a video-based tracking system (Any-Maze, Stoelting, WI, 
USA). Animals were returned to their home cages at the end of each testing period. 
Following the last day of testing, animals remained in their home cages in the colony for 
10 – 14 days before electrophysiology experiments were performed. To determine 
whether repeated cocaine treatment produced behavioral sensitization, the locomotor 
activity (distance traveled) during the first 30 minutes of the session on Day 1 and Day 5 
was compared, pooling all cocaine-treated animals. A t-test was used to confirm a 
significant difference in locomotor activity between Day 1 and Day 5, indicating the 
development of behavioral sensitization to cocaine.   
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Ex vivo drug application 
Drugs were prepared in a stock solution and added at the final concentration to the 
ACSF bath solution. A between-cell experimental design was utilized in which slices 
were first placed in a separate chamber containing the drug or control ACSF prior to 
recording synaptic activity. For these ex vivo experiments, slices were exposed to one of 
the following conditions:  
1) no challenge (exposure to ACSF only) 
2) ex vivo cocaine challenge (10 µM; 10 min) 
3) ex vivo MTEP (specific mGluR5 antagonist; 5 µM; 10 min) or cycloheximide 
(protein synthesis inhibitor; 60 µM; 30 min) alone. 
 4) ex vivo MTEP or cycloheximide (10 min) followed by 10 µM cocaine + 
antagonist (10 min).  
 
Figure 1.1. Timeline of experimental manipulations. Mice received five once-daily injections 
of cocaine or saline, followed by 10-14 days of abstinence in their home cages. Brain slices were 
prepared following the abstinence period. To examine the role of mGluR5 and protein synthesis, 
the mGluR5 inhibitor MTEP (5 µM) or the protein synthesis inhibitor cyclohexamide (60 µM) 
was applied prior to and during ex vivo cocaine. Recording took place immediately following 
drug conditions. 
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Following the timed drug exposure, slices were transferred to the recording chamber 
where standard ACSF continuously perfused the slices. Recordings took place up to 1 
hour following ex vivo drug exposure. 
 
Slice electrophysiology 
Following 10–14 days of abstinence from cocaine treatment, mice were 
anesthetized with isoflurane, decapitated, and the brain rapidly removed. Parasagittal 
slices (250 µm) containing the nucleus accumbens shell and core were prepared in ice-
cold artificial cerebrospinal fluid (ACSF) saturated with 95% O2 / 5% CO2 and 
containing (in mM): 6 kynurenic acid, 119 NaCl, 2.5 KCl, 1.0 NaH2PO4, 26.2 NaHCO3, 
11 glucose, 1.3 MgSO4, and 2.5 CaCl2. Slices rested for at least 30 min in a holding 
chamber at room temperature containing standard ACSF continuously saturated with 
95% O2 / 5% CO2 and composed of (in mM): 119 NaCl, 2.5 KCl, 1.0 NaH2PO4, 26.2 
NaHCO3, 11 glucose, 1.3 MgSO4, and 2.5 CaCl2. During recording, picrotoxin (100 µM) 
and lidocaine (0.7 µM) were included to block GABAA-mediated inhibitory transmission 
and action potentials, respectively. Neurons in the NAc shell were visualized on an 
upright microscope using infrared differential interference contrast (IR-DIC) optics. 
MSNs were identified by their morphology and hyperpolarized resting membrane 
potential (-70 to -80 mV). To assess excitatory synaptic transmission mediated by 
AMPARs, cells were voltage-clamped at -80 mV using an Axon Instruments MultiClamp 
700A (Molecular Devices, Sunnyvale, CA, USA). Patch pipettes (3-5 MΩ) were filled 
with a cesium-gluconate-based internal solution containing (in mM): 117 cesium 
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gluconate, 2.8 NaCl, 20 HEPES, 0.4 EGTA, 5 tetraethylammonium-Cl, 2 MgATP, and 
0.3 MgGTP (pH 7.2-7.4). Data were filtered at 2 kHz, digitized at 5 kHz, and collected 
using custom Igor Pro software (Wavemetrics, Lake Oswego, OR, USA). A depolarizing 
step (4 mV, 100 ms) was generated at the beginning of each sweep to monitor series 
resistance (10-40 MΩ) and input resistance (>500 MΩ). MiniAnalysis software 
(Synaptosoft, Decatur, GA, USA) was used offline to analyze mEPSC amplitude and 
frequency.  
  
2.5 Drugs  
Cyclohexamide and MTEP were purchased from Tocris Bioscience (Bristol, 
United Kingdom). Lidocaine and picrotoxin were purchased from Sigma Aldrich (St. 
Louis, MO, USA).  Cocaine was obtained from Boynton Health Services Pharmacy 
(University of Minnesota, Minneapolis, MN, USA). Drugs were prepared in a stock 
solution at 100 – 1000 times the desired concentration and added into standard ACSF at 
the final concentration.   
 
2.5 Statistical analysis 
All data are presented as group mean ± SEM. Statistical significance was assessed 
with a Student’s t-test or one-way ANOVA using JMP Pro (SAS, Cary, NC, USA) and 
GraphPad Prism (GraphPad Software, La Jolla, CA, USA). Tukey HSD post hoc tests 
were used for pairwise comparisons where appropriate. The threshold for significance 
was p<0.05.  
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Results 
In the striatum, group I mGluRs prominently mediate the induction of synaptic 
depression at excitatory synapses on MSNs  (Lüscher and Huber, 2010). In the NAc, 
activation of post-synaptic group I mGluRs has been shown to promote reduced 
presynaptic glutamate release probability and increased trafficking of AMPARs 
(McCutcheon et al., 2011; Robbe et al., 2002). Thus, we investigated whether blockade 
of mGluR5-dependent signaling with ex vivo application of the antagonist MTEP 
prevents the cocaine-induced depotentiation of AMPAR-mediated signaling in the NAc 
shell and core. 
 
Activation of mGluR5 in the NAc shell but not core is necessary for cocaine-induced 
synaptic depotentiation. 
Mice were treated with five once-daily injections of saline or cocaine (15 mg/kg 
i.p.) that produced robust behavioral sensitization (137.1 ± 9.865 mean difference in 
meters travelled/30 min between injection day 1 and day 5; t(1,22) = 13.9, p<0.0001). 
Following 10-14 days of abstinence, animals were sacrificed and acute slices containing 
the NAc shell were prepared. As demonstrated in previous experiments from our lab 
(Jedynak et al., 2016), cocaine pre-treatment increased the amplitude (measured in 
picoamperes of current, pA) of mEPSCs, a direct measure of AMPAR function, in shell 
MSNs, which was subsequently reversed by an ex vivo cocaine bath challenge (figure 
1.2B-left; Sal (10.87 ± 0.46, 8 cells/4 animals), Coc (14.62 ± 0.90, 11 cells/5 animals), 
Coc–Coc (10.52 ± 0.32, 9 cells/5 animals); F(6,71)=5.93, p<0.001). However, incubation 
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of acute slices in MTEP (5 μM) prior to cocaine challenge prevented the cocaine-induced 
reductions in mEPSC amplitude (figure 1.2B-left; Coc–MTEP–Coc (14.05 ± 0.49, 8 
cells/3 animals), p<0.001). Interestingly, MTEP pre-treatment did not prevent the cocaine 
challenge-induced reversal of AMPAR mEPSC frequency (events per second, Hz) 
[figure 1.2B-right; Sal (3.95 ± 0.42), Coc (5.78 ± 0.61), Coc–Coc (3.33 ± 0.36), Coc–
MTEP–Coc (3.87 ± 0.50); F(6,66)=3.90, p=0.002]. Additionally, in slices from cocaine-
treated animals, while bath application of MTEP alone had no effect on baseline mEPSC 
amplitudes (Coc–MTEP: 13.80 ± 0.52) or frequency (Coc–MTEP: 6.27 ± 1.11) (data not 
shown), MTEP application to slices from saline-treated animals (Sal–MTEP) 
significantly increased mEPSC amplitude (14.20 ± 0.97) and trended toward elevating 
frequency (6.21 ± 1.02, p=0.089) (data not shown) compared with saline-no challenge 
controls.  
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Figure 1.2. Activation of mGluR5 in the NAc shell is necessary for cocaine-induced synaptic 
depotentiation. (A) Representative mEPSC current traces from NAc shell neurons. (B) Mean 
mEPSC amplitude and frequency in the NAc shell from saline (Sal), cocaine + no challenge 
(Coc), cocaine + cocaine challenge (Coc-coc), cocaine + MTEP/cocaine (Coc-MTEP-Coc). All 
data are presented as mean ± SEM. *p<0.05 vs. Coc, ** p<0.01 vs. Coc, *** p<0.001 vs Coc; # 
p<0.05 vs. Coc-MTEP-Coc, ## p<0.01 vs. Coc-MTEP-Coc. 
 
 
In the NAc core, cocaine significantly increased mEPSC amplitude compared 
with saline controls [figure 1.3B-left; Sal (11.41 ± 0.48, 9 cells/4 animals), Coc (14.20 ± 
1.08, 8 cells/4 animals), Coc–Coc (11.30 ± 0.43, 14 cells/5 animals); F(5,57)=4.57, 
p=0.002]; however, unlike the shell, incubation of acute slices in MTEP prior to cocaine 
bath challenge failed to prevent the reduction in mEPSC amplitude [figure 1.3B-left; 
Coc–MTEP–Coc (11.85 ± 0.97, 11 cells/3 animals), p<0.002]. MTEP application alone 
had no effect on mEPSC amplitude in slices from saline- (Sal–MTEP: 14.20 ± 1.08) or 
cocaine-treated mice (Coc–MTEP: 14.51 ± 1.04) (data not shown) compared with their 
respective controls. No significant effects were observed on mEPSC frequency in the 
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NAc core (figure 1.3B-right; F(5,57)=2.04, p=0.09). Thus, while the phenomena of 
cocaine-induced depotentiation in the NAc core versus shell are outwardly similar, the 
mechanisms appear to be different, with NAc shell depotentiation relying on mGluR5 
activation.  
 
 
Figure 1.3. Synaptic depotentiation in the NAc core does not require mGluR5 activity. (A) 
Representative mEPSC current traces from NAc core neurons. (B) Mean mEPSC amplitude and 
frequency in the NAc core from saline (Sal), cocaine + no challenge (Coc), cocaine + cocaine 
challenge (Coc-coc), cocaine + MTEP/cocaine (Coc-MTEP-Coc). All data are presented as mean 
± SEM. ** p<0.01 vs. Coc, *** p<0.001 vs Coc. 
 
 
Protein synthesis mediates depotentiation of AMPAR signaling in the NAc shell 
A common mechanism for mGluR-dependent long-term depression in many brain 
regions, including the striatum, is the reliance on rapid protein synthesis (Lüscher and 
Huber, 2010; Yin and Lovinger, 2006). Since we observed that mGluR5 signaling 
selectively mediates depotentiation of AMPAR synaptic strength in the NAc shell, we 
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chose to focus this investigation on the NAc shell, excluding the core. Consistent with an 
mGluR5 mechanism, we found that incubation of slices from cocaine-treated mice in the 
protein translation inhibitor cyclohexamide (60 μM) for 30 min prior to cocaine bath 
challenge also prevented reductions in mEPSC amplitude [figure 1.4B-left; Sal (10.87 ± 
0.46, 8 cells/4 animals), Coc (14.62 ± 0.90, 11 cells/5 animals), Coc–Coc (10.52 ± 0.32, 9 
cells/5 animals); Coc–Cyclo–Coc (13.45 ± 0.60, 14 cells/6 animals), F(6,66) =5.93, 
p<0.001]. However, similar to the MTEP findings, cycloheximide pre-treatment did not 
prevent the cocaine challenge-induced depotentiation of AMPAR mEPSC frequency 
[figure 1.4B-right; Sal (3.95 ± 0.42), Coc (5.78 ± 0.61), Coc–Coc (3.33 ± 0.36); Coc–
Cyclo–Coc (3.52 ± 0.56); F(6,66)=3.90, p=0.002]. These findings confirm that 
depotentiation of synaptic strength in the NAc shell during abstinence from cocaine 
requires rapid protein synthesis, suggesting selective engagement of mGluR5 and protein 
synthesis mechanisms in the shell. 
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Figure 1.4. NAc shell synaptic depotentiation requires protein synthesis. (A) Representative 
mEPSC current traces from NAc shell neurons. (B) Mean mEPSC amplitude and frequency in the 
NAc shell from saline (Sal), cocaine + no challenge (Coc), cocaine + cocaine challenge (Coc-
coc), cocaine + Cyclo/cocaine (Coc-Cyclo-Coc). All data are presented as mean ± SEM. *p<0.05 
vs. Coc, ** p<0.01 vs. Coc; # p<0.05 vs. Coc-Cyclo-Coc. 
 
Discussion 
Group I mGluRs are widely expressed throughout the brain, comprising a 
dominant mechanism for modulating synaptic efficacy and plasticity at glutamatergic 
synapses. In the striatum, mGluR1/5 signaling has been demonstrated to critically 
regulate circuits that influence motivated learning and behavior, as well as reward and 
reinforcement (Olive, 2010; Philibin et al., 2011). Expanding on previous studies 
investigating the role of mGluR5 in cocaine-seeking behavior (Kumaresan et al., 2009; 
Schmidt et al., 2013), we found here that depotentiation of enhanced AMPAR synaptic 
transmission in the NAc requires mGluR5 signaling, indicating that cocaine re-exposure 
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during abstinence engages mGluR5 signaling mechanisms that promote a reduction in 
AMPAR-mediated synaptic strength.  
Following protracted abstinence or extinction from repeated cocaine exposure,  
renewed exposure to cocaine transiently increases glutamate release in the NAc 
(McFarland et al., 2003; Pierce et al., 1996; Reid and Berger, 1996), an effect that has 
been demonstrated to be a causal factor driving reinstatement behavior (Baker et al., 
2003). Augmentation of glutamatergic transmission elicited by drug re-exposure indicates 
a means by which mGluR5 may be engaged by glutamatergic signaling in the NAc. 
mGluR5s are densely expressed in the NAc (Lu et al. 1999), where they provide a 
prominent mechanism for reducing synaptic transmission at excitatory synapses. 
Activation of these receptors may therefore provide a mechanism for decreasing the 
responsiveness of MSNs to glutamatergic input, dampening potentiated excitatory 
synaptic transmission.  
Throughout the brain, mGluR1/5 couples to intercellular mechanisms that 
promote synaptic depression through endocytosis of AMPARs. Indeed, studies in the 
hippocampus (Gladding et al., 2009; Snyder et al., 2001) and bed nucleus of the stria 
terminalis (Grueter et al., 2008) have repeatedly demonstrated that mGluR1/5-mediated 
LTD is post-synaptically maintained through AMPAR endocytosis. In the NAc, while 
mGluR1/5-LTD involves a significant pre-synaptic contribution due to mGluR1/5-
mediated mobilization of endogenous cannabinoids that negatively regulate glutamate 
release probability (Robbe et al., 2002), evidence indicates that mGluR-1/5 synaptic 
depression is also expressed through post-synaptic endocytosis of AMPARs 
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(Mangiavacchi and Wolf, 2004a; McCutcheon et al., 2011). In the NAc, mGluR1/5 
signaling is therefore capable of both reducing the strength of excitatory drive as well as 
the post-synaptic sensitivity of NAc MSNs to glutamatergic input.  
This rapid dampening of glutamatergic synaptic strength may be a critical factor 
in triggering a renewal of cocaine seeking behavior, given that activation of NAc 
mGluR5 during abstinence or extinction is sufficient to induce cocaine-primed and cue-
primed reinstatement behavior (Schmidt et al., 2013; Wang et al., 2013). Our data here 
demonstrates that during abstinence from repeated cocaine, mGluR5 signaling in the NAc 
is necessary for the reversal of potentiated AMPAR signaling induced by cocaine re-
exposure ex vivo, preventing the induction of synaptic depotentiation normally produced 
by cocaine. 
 However, these findings contrast with other evidence suggesting that mGluR1/5-
mediated synaptic depression in the NAc is impaired following chronic cocaine exposure. 
During abstinence from repeated cocaine, the ability of the mGluR1/5 agonist DHPG to 
induce synaptic depression at NAc MSN synapses is impaired (Huang et al., 2011), an 
effect that is not dependent on MSN cell sub-type (Huang et al., 2015). This could reflect 
a downregulation of mGluR1/5 total expression (Huang et al., 2011) or cell surface levels 
observed by a number of studies following chronic cocaine exposure (Knackstedt et al., 
2010; Swanson et al., 2001). Moreover, impairment of mGluR1/5-LTD has been 
suggested to be region-specific, as different groups have observed impaired mGluR1/5 
plasticity in the NAc shell (Huang et al., 2011) or core (Swanson et al., 2001) during 
protracted abstinence from cocaine. Indeed, we observed that application of the mGluR5 
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antagonist MTEP was effective at preventing the cocaine-induced depotentiation 
selectively in the NAc shell, without blocking the induction of plasticity in the NAc core. 
This could reflect a specific loss of mGluR5-mediated efficacy at NAc core synapses due 
to decreased receptor availability; however, given the limited observations of this effect, 
more research is needed to characterize alterations in mGluR5 expression levels, presence 
on the cell surface, or coupling with intercellular signaling mechanisms that mediate a 
reduction in synaptic transmission.  
Additionally, many of the studies cited above did not differentiate between 
mGluR1 and mGluR5 pharmacologically, using the group I mGluR agonist DHPG to 
induce mGluR1/5-LTD in the NAc. Given that these receptor sub-types have been shown 
to mediate divergent effects on NAc synaptic plasticity and addiction-related behavior, it 
is possible that the impairment of plasticity observed in the NAc is due to engagement of 
mechanisms outside of mGluR5 alone. Furthermore, while studies of mGluR1/5-LTD 
have typically characterized this form of plasticity in the NAc using electrical stimulation 
or pharmacological activation, these induction mechanisms may differ from the 
mechanisms in the present study engaged by cocaine exposure. Understanding how 
mGluR1/5 signaling modulates synaptic transmission will require elucidating 
mechanisms specific to the method of induction. 
 Downstream of mGluR1/5 activation, rapid protein synthesis critically maintains 
LTD through interactions with AMPAR endocytosis machinery (Park et al., 2008; 
Waung et al., 2008). A number of studies have demonstrated that mGluR1/5-mediated 
LTD relies on protein translation within local dendrites (Lüscher and Huber, 2010). This 
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rapid form of protein synthesis is activated following chronic cocaine experience: for 
example, a recent study revealed that protein synthesis is necessary to maintain high 
levels of calcium-permeable AMPARs during extended abstinence from cocaine 
administration (Scheyer et al., 2014). Thus, protein synthesis may assist in regulating 
trafficking and endocytosis of AMPARs at the synapse as a consequence of cocaine 
exposure. We observed that in the NAc shell, the depotentiation of AMPAR-mediated 
signaling requires both mGluR5 signaling and rapid protein translation (within 30 min). 
Future studies will be required to identify candidate proteins mediating synaptic 
depotentiation downstream of mGluR5 activation. 
 In summary, these findings define a role for mGluR5-mediated signaling in the 
NAc shell in mediating cocaine-induced depotentiation of AMPAR synaptic strength. We 
identify that mGluR5 is selectively engaged in the NAc shell, not core, during abstinence 
from cocaine. Furthermore, the plasticity induced by cocaine re-exposure requires rapid 
protein synthesis, indicating a mechanism through which mGluR5 activity promotes the 
rapid induction of AMPAR endocytosis.  
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Chapter 2: Temporal characteristics of cocaine-induced  
AMPAR plasticity in the NAc shell. 
 
Introduction    
Studies of drug-evoked alterations in glutamatergic synaptic function indicate 
dynamic and complex regulation of AMPARs in the NAc following cocaine 
administration. Data from our lab and others has shown that during abstinence or 
extinction from repeated cocaine, cell surface expression of AMPARs in the NAc is 
increased (Boudreau and Wolf, 2005) and AMPAR-mediated currents are enhanced 
(Kourrich et al., 2007; McCutcheon et al., 2011; Ortinski et al., 2012; Pascoli et al., 2011; 
Rothwell et al., 2011), an effect that is not present during early abstinence or following a 
single acute injection of cocaine (Kourrich et al., 2007). Increased AMPAR sensitivity at 
NAc MSNs therefore appears to be sensitive to the length of abstinence or extinction 
following drug exposure, requiring several days to weeks to develop. As we have 
previously reported (Jedynak et al., 2016), renewed cocaine exposure during abstinence 
depotentiates enhanced AMPAR synaptic strength, apparently resetting synapses to a 
basal state similar to non-drug conditions. However, the temporal parameters of this re-
exposure-induced plasticity have not been well defined, including how rapidly AMPAR 
depotentiation is induced and whether this plasticity is transient or long-lasting.  
The present study investigated the temporal parameters of NAc shell synaptic 
depotentiation, examining 1) the duration of AMPAR synaptic depotentiation induced by 
an in vivo cocaine challenge; and 2) the timecourse of synaptic depotentiation onset, 
utilizing an ex vivo cocaine challenge approach. 
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Materials and methods 
Animals   
Adult male (P49-70) C57BL/6 mice (Jackson Laboratories, Bar Harbor, Maine, 
USA) were used. All animals were group-housed in a temperature- and humidity-
controlled environment on a 12 hr light/12 hr dark cycle, with food and water available 
ad libitum. All experiments were approved by the Institutional Animal Care and Use 
Committee at the University of Minnesota. 
 
2.2 Behavioral sensitization 
Prior to testing, mice were habituated to experimenter handling, i.p. injections, 
and the testing environment (individual activity boxes, 8.5 x 17.5 x 9 in) over two days. 
On five consecutive testing days, mice were habituated to the testing environment for 30 
minutes (min) before receiving an intraperitoneal injection of either cocaine (15 mg/kg) 
or saline. Mice were immediately placed back into the testing environment, and their 
activity was monitored for 90 min using a video-based tracking system (Any-Maze, 
Stoelting, WI, USA). Animals were returned to their home cages at the end of each 
testing period. Following the last day of testing, animals remained in their home cages in 
the colony for 10 – 14 days before electrophysiology experiments were performed. For in 
vivo drug challenge experiments only, mice were handled and injected with saline during 
the last 2 days of the 10 – 14 day abstinence period to prevent any potential effects of 
stress during the challenge experiment. Mice were habituated to the testing environment 
for 30 min before receiving a challenge injection of cocaine (15 mg/kg) or saline, 
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followed by activity monitoring for 90 min. Electrophysiology experiments took place 
within 24 hours (h) or 5 days (d) following the challenge injection. 
To determine whether repeated cocaine treatment produced behavioral 
sensitization, the locomotor activity (distance traveled) during the first 30 minutes of the 
session on Day 1 and Day 5 was compared, pooling all cocaine-treated animals. A t-test 
was used to confirm a significant difference in locomotor activity between Day 1 and 
Day 5, indicating the development of behavioral sensitization to cocaine. Animals that 
did not fit these criteria were excluded from recording experiments. In this and 
subsequent chapters, behavioral data will not be reported; see Chapter 1 for a full 
description.  
 
Slice electrophysiology 
 Following 10–14 days of abstinence from cocaine treatment or either 24 hr or 5 d 
after an in vivo cocaine challenge injection, mice were anesthetized with isoflurane, 
decapitated, and the brain rapidly removed. Parasagittal slices (240 µm) containing the 
nucleus accumbens shell were prepared in 2-4°C sucrose-containing artificial 
cerebrospinal fluid (ACSF), after which slices rested for at least 30 min in standard 
ACSF at room temperature. To assess AMPAR-mediated excitatory synaptic 
transmission, cells were voltage-clamped at -80 mV using an Axon Instruments 
MultiClamp 700A (Molecular Devices, Sunnyvale, CA, USA). Data were filtered at 2 
kHz, digitized at 5 kHz, and collected using custom Igor Pro software (Wavemetrics, 
Lake Oswego, OR, USA). MiniAnalysis software (Synaptosoft, Decatur, GA, USA) was 
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used offline to analyze mEPSC amplitude, frequency, rise time, and decay time. To 
determine the rise time and decay time, two exponentials were fit to the rise time or 
decay time of mEPSCs using the MiniAnalysis curve-fitting function, and the time 
constant was calculated between 10-90% of peak. For a more detailed description of slice 
preparation and recording methods, see Chapter 1. 
 
Ex vivo drug application 
For cocaine ex vivo experiments, cocaine was prepared in a stock solution and 
added at the final concentration of 10 µM to the ACSF perfusing the slices. Initial 
experiments attempted to utilize a within-cell design in which baseline mEPSCs were 
collected in standard ACSF followed by continued recording in 10 µM cocaine ACSF. 
However, we found that recordings became extremely unstable during bath application of 
cocaine, producing low quality data. Thus, we utilized a between-cell experimental 
design in which slices were bathed in cocaine ACSF for 10 minutes and then switched to 
perfusing with standard ACSF for recording. Recordings took place up to 1 hour 
following ex vivo drug exposure, and the time elapsed between drug exposure and the 
beginning of a recording was noted to determine whether the amount of time following 
drug exposure was a factor in synaptic plasticity. 
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Figure 2.1. Timeline of experimental manipulations. Mice received five once-daily injections 
of cocaine or saline, followed by 10-14 days of abstinence in their home cages. For in vivo 
challenge experiments, animals received a cocaine challenge injection following the abstinence 
period. Recording took place 24 hours or 5 days following the challenge. For ex vivo 
experiments, brain slices were prepared following the abstinence period. Cocaine challenge was 
carried out ex vivo, after which recordings took place immediately. Recordings were binned into 
groups according to the time elapsed between ex vivo challenge and the start of recording: 20, 40, 
and 60 minutes.  
 
 
 2.5 Drugs  
Lidocaine and picrotoxin were purchased from Sigma Aldrich (St. Louis, MO, 
USA). Cocaine was obtained from Boynton Health Services Pharmacy (University of 
Minnesota, Minneapolis, MN, USA). Drugs were prepared in a stock solution at 100 – 
1000 times the desired concentration and added into standard ACSF at the final 
concentration.  
 
2.5 Statistical analysis 
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All data are presented as group mean ± SEM. Statistical significance was assessed 
with a Student’s t-test, one-way ANOVA, or two-way ANOVA using JMP Pro (SAS, 
Cary, NC, USA) and GraphPad Prism (GraphPad Software, La Jolla, CA, USA). Tukey 
HSD post hoc tests were used for pairwise comparisons where appropriate. The threshold 
for significance was p<0.05.  
 
Results 
 
Cocaine-induced potentiation of AMPAR synaptic transmission in the NAc shell is 
reversed by in vivo cocaine challenge and persists for fewer than 5 days post challenge. 
Previous studies examining cocaine-induced AMPAR plasticity in the NAc have 
shown that the ability of intra-NAc AMPA to induce locomotor activity is decreased 24 
hours but not 6 days following a cocaine challenge (Bachtell and Self, 2008), indicating 
that cocaine challenge-induced plasticity in the NAc is transient in nature. To investigate 
the duration of AMPAR synaptic plasticity in the NAc shell, we performed ex vivo 
recordings of mEPSCs, a direct measure of synaptic AMPAR function, 24 hours or 5 
days following a cocaine challenge injection (given on day 10-14 of abstinence). Twenty-
four hours following cocaine challenge, mEPSC amplitude (picoamperes of current, pA) 
and frequency (events per second, Hz) were significantly reduced compared to cocaine-
treated animals receiving a saline challenge [amplitude (figure 2.2B-left): Sal (11.29 ± 
0.40, 7 cells/3 animals); Coc (14.50 ± 0.97, 8 cells/5 animals); Coc-coc 24h (10.84 ± 
0.42, 9 cells/3 animals); F(3,29) = 7.72, p=0.0006); frequency (figure 2.2B-right): Sal (3.80 
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± 0.44); Coc (5.52 ± 0.30); Coc-coc 24h (3.55 ± 0.28); F(3,29) = 6.04, p=0.0026]. 
However, 5 days following in vivo cocaine challenge, neither mEPSC amplitude (14.60 ± 
0.89) nor frequency (5.93 ± 0.80) (9 cells, 3 animals) were significantly different from 
cocaine-treated controls receiving no challenge injection. Additionally, no differences in 
AMPAR mEPSC rise time kinetics [Sal (3.26 ± 0.35); Coc (2.70 ± 0.14); Coc-coc 24h 
(3.33 ± 0.10); Coc-coc 5d (3.00 ± 0.10); F(3,20)=0.73, p=0.55, data not shown) or decay 
time kinetics [Sal (3.24 ± 0.19); Coc (3.73 ± 0.15); Coc-coc 24h (3.93 ± 0.30); Coc-coc 
5d (3.93 ± 0.21); F(3,20)=2.31, p=0.11, not shown] were observed. 
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Figure 2.2. Cocaine-induced potentiation of AMPAR synaptic transmission in the NAc shell 
is reversed by in vivo cocaine challenge and persists for fewer than 5 days post challenge. 
(A) Representative mEPSC current traces from NAc shell neurons. (B) Mean mEPSC amplitude 
and frequency in the NAc shell from saline + no challenge (sal), cocaine + no challenge (Coc), 
cocaine + cocaine challenge at 24h (Coc-coc 24h); cocaine + cocaine challenge at 5d (Coc-coc 
5d). (D) Cumulative probability distributions of mEPSC amplitude and inter-event interval from 
saline + no challenge (Sal), cocaine + no challenge (Coc), cocaine + cocaine challenge at 24h 
(Coc-coc 24h), cocaine + cocaine challenge at 5d (Coc-coc 5d). All data are presented as mean ± 
SEM. * p≤0.05 vs. Coc, ** p≤0.01 vs Coc; # p≤0.05 vs Coc-coc 5d, ## p≤0.01 vs Coc-coc 5d. 
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Ex vivo cocaine re-exposure induces depotentiation of AMPAR signaling in the NAc shell 
that is maximally expressed within 20 minutes post challenge. 
Studies investigating cocaine-induced reversal of synaptic potentiation in the NAc 
have characteristically observed synaptic plasticity at 2-24 hours following in vivo 
cocaine challenge injection, leaving open the question of how rapidly plasticity is 
induced by cocaine re-exposure (Bachtell and Self, 2008; Boudreau et al., 2007; Kourrich 
et al., 2007; Rothwell et al., 2011). To examine this, we utilized a recently developed ex 
vivo model of cocaine re-exposure which our lab has shown to reverse the increase in 
NAc shell AMPAR transmission produced by repeated in vivo cocaine exposure (Jedynak 
et al., 2016). Following bath application of cocaine, recordings of mEPSCs were 
performed in the NAc shell for up to 1 hour, with cells binned into 20-, 40-, and 60-min 
timing groups based on the time elapsed between cocaine challenge and recording. 
Consistent with previous studies (Jedynak et al., 2016; Kourrich et al., 2007), the 
amplitude and frequency of mEPSCs were elevated in MSNs from cocaine-treated 
animals in the NAc shell, indicating potentiation of AMPAR synaptic transmission 
during abstinence [amplitude (figure 2.3B-left): Coc (13.65 ± 0.38, 23 cells/19 animals); 
frequency (figure 2.3B-right): Coc (6.8 ± 0.58)]. Following ex vivo challenge at all time 
intervals, we observed a significant decrease in mEPSC amplitude and frequency, with a 
~30% reduction in AMPAR-mediated signaling observed equally at all three post-
challenge timepoints [amplitude (figure 2.3B-left): 20 min (9.62 ± 0.40, 7 cells/6 
animals); 40 min (10.30 ± 0.65, 6 cells/6 animals); 60 min (10.46 ± 0.60, 7 cells/6 
animals); F(3,46) =14.36, p<0.0001; frequency (figure 2.3B-right): 20 min (3.95 ± 0.49); 
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40 min (3.44 ± 0.22); 60 min (3.44 ± 0.37); F(3,46)=9.03, p<0.0001]. No differences in rise 
time kinetics (milliseconds, ms) [Coc (3.29 ± 0.08); 20 min (3.53 ± 0.19); 40 min (3.60 ± 
0.20); 60 min (3.58 ± 0.23); F(3,32)=1.21, p=0.32, data not shown) or decay time kinetics 
(milliseconds, ms) [Coc (4.11 ± 0.15); 20 min (4.12 ± 0.21); 40 min (3.72 ± 0.38); 60 min 
(4.24 ± 0.36); F(3,34)=0.62, p=0.61, not shown] were observed in AMPAR mEPSCs. 
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Figure 2.3 Ex vivo cocaine re-exposure induces depotentiation of AMPAR signaling in the 
NAc shell that is maximally expressed within 20 minutes post challenge. (A) Representative 
miniature excitatory postsynaptic current (mEPSC) traces from NAc shell neurons. (B) Mean 
mEPSC amplitude and frequency in the NAc shell from cocaine + no challenge (Coc), cocaine + 
cocaine 20 min post challenge (Coc-coc 20), cocaine + cocaine 40 min post challenge (Coc-coc 
40), cocaine + cocaine 60 min post challenge (Coc-coc 60). (D) Cumulative probability 
distributions of mEPSC amplitude and inter-event interval from cocaine + no challenge (Coc-sal), 
cocaine + cocaine 20 min post challenge (Coc-coc + 20), cocaine + cocaine 40 min post challenge 
(Coc-coc + 40), cocaine + cocaine 60 min post challenge (Coc-coc + 60). All data are presented 
as mean ± SEM. ** p≤0.01 vs. Coc, *** p≤0.001 vs Coc.  
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Discussion 
 
The current study investigated the temporal profile of bidirectional AMPAR 
plasticity in the NAc shell following re-exposure to cocaine during abstinence. Here, we 
find that ex vivo cocaine re-exposure rapidly induces depotentiation of AMPAR-mediated 
signaling in the NAc shell on a timescale of less than 20 minutes. Furthermore, this 
plasticity persists for at least 24 hours but not five days following a cocaine challenge 
injection, after which synapses return to “repotentiated” levels of synaptic strength. These 
findings have implications for understanding how the timing of drug use and subsequent 
re-use following periods of abstinence can differentially alter excitatory synaptic 
transmission in the NAc.  
Our finding that NAc shell synapses are repotentiated within five days following 
renewed cocaine exposure is consistent with previous work demonstrating a re-
emergence of potentiated AMPAR signaling following a similar time interval after 
cocaine re-exposure: the ability of an intra-NAc infusion of AMPA to augment locomotor 
activity is abolished 24 hours following cocaine challenge, but regains efficacy six days 
after the challenge injection (Bachtell and Self, 2008). This “rebound effect” was 
similarly observed in a study reporting that surface expression of AMPARs in the NAc is 
decreased 24 hours after cocaine challenge but returns to pre-challenge levels of 
expression after seven days of abstinence (Ferrario et al., 2009). Coupled with our data, 
these observations might suggest that the potentiation of AMPAR synaptic strength 
evoked by the initial repeated cocaine treatment regimen produces plasticity that appears 
to be more durable and longer-lasting than depotentiation induced by cocaine re-
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exposure, such that cocaine re-exposure temporarily induces a relative reduction in 
synaptic strength, after which synapses return to potentiated levels.  
Rapid shifts in synaptic AMPAR content in the NAc could reflect the engagement 
of homeostatic mechanisms functioning to counteract the alterations in glutamatergic 
signaling that arise during periods of abstinence and drug re-exposure. Indeed, increased 
surface expression of post-synaptic AMPARs has been suggested to be a mechanism 
expressed to maintain synaptic glutamate homeostasis, counteracting the decreased 
glutamate tone and reduced neuronal excitability in the NAc that emerges during 
abstinence from chronic cocaine treatment cocaine (Baker et al., 2003; Kourrich and 
Thomas, 2009; Kourrich et al., 2007). Transient elevations in glutamate during cocaine 
re-exposure (Baker et al., 2003) would be expected to disrupt this balance, eliciting 
downregulation of AMPAR signaling. Our data indicates that excitatory synapses in the 
NAc shell appear to recover and regain their heightened AMPAR sensitivity within a 
relatively short period following cocaine re-exposure. 
Here, we found that cocaine re-exposure engages mechanisms of plasticity that 
occur rapidly and are maximally expressed in within 20 minutes. While the rapid 
induction of cocaine-evoked plasticity is striking, it is consistent with previous literature 
demonstrating that ex vivo cocaine is capable of dynamically modifying AMPAR 
synaptic strength in the NAc on a short timescale of 10-20 minutes (Dobbs et al., 2016; 
Harvey and Lacey, 1996; Nicola, 1996). In terms of this study, the induction of plasticity 
on a brief timescale constrains the potential molecular and cellular mechanisms that 
might be engaged by cocaine re-exposure. Regulation of AMPAR endocytosis machinery 
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likely mediates the rapid alterations in AMPAR synaptic levels (Bachtell and Self, 2008; 
Brebner et al., 2005). While changes in gene expression are unlikely to occur on such a 
short timescale, on-demand protein translation occurring locally in dendrites has been 
shown to mediate rapid increases in AMPAR endocytosis culminating in a reduction in 
synaptic strength in the NAc (Lüscher and Huber, 2010; Waung et al., 2008), consistent 
with previous findings from our lab demonstrating that rapid protein synthesis is 
necessary for cocaine-induced synaptic depotentiation (Chapter 1). Thus, the rapid 
induction of plasticity that we observe here likely engages common mechanisms for 
dynamically regulating excitatory synaptic strength in the NAc. 
In conclusion, these findings acknowledge the existence of multiple overlapping 
forms of plasticity at NAc synapses that likely serve to regulate and update synaptic 
strength as a consequence of varied drug experiences. Initially, abstinence from repeated 
cocaine initiates mechanisms that promote enhanced glutamatergic synaptic transmission, 
which develops gradually over time and is observed only during late abstinence 
(Kourrich et al., 2007; Ortinski et al., 2012; Wolf, 2010). The mechanisms and the time 
course of this plasticity are distinct from the rapid reduction in AMPAR-mediated 
synaptic transmission induced by cocaine re-exposure, demonstrating that synapses 
altered by cocaine exposure remain plastic and are capable of undergoing further 
modifications by drug re-exposures. Synaptic depotentiation is constrained to a relatively 
short amount of time, after which NAc shell synapses return to a potentiated state. This 
modification of synapses through potentiation, depotentiation, and re-potentiation might 
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represent how neural circuits continually update and maintain relevant drug-related 
memory traces at activated synapses. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  45 
Chapter 3: Endogenous dopamine and endocannabinoid signaling mediate 
reversal of AMPAR synaptic potentiation in the NAc shell. 
 
Introduction 
Neuromodulators are key regulators of neuronal activity, modifying the 
excitability of cells and shaping synaptic input to alter large-scale network dynamics and 
subsequently influence behavioral and cognitive states (Lee and Dan, 2012; Melis et al., 
2014). Furthermore, neuromodulators regulate critical aspects of synaptic plasticity 
through a number of mechanisms including adjusting the threshold for plasticity 
induction, regulating the maintenance of long-term forms of plasticity, and modifying a 
host of cellular mechanisms mediating synaptic plasticity (Mameli et al., 2009; 
Marsicano and Lutz, 2006; Melis et al., 2014). Given the critical functions of 
neuromodulators on neural activity and plasticity throughout the brain, dysfunctional 
neuromodulation may play a key role in a number of disease conditions, including 
addiction (Fernández-Ruiz et al., 2010; Lüscher and Huber, 2010).   
 
Dopamine modulation of glutamatergic synaptic plasticity 
Prominent among these neuromodulators, dopamine (DA) regulates glutamatergic 
synaptic transmission in the striatum, gating the excitability, activity, and induction of 
plasticity at NAc MSN synapses (Calabresi et al., 2007; Gerfen and Surmeier, 2011; 
Tritsch and Sabatini, 2012). DA receptors are located on both pre-synaptic afferents to 
the NAc and on MSNs themselves, and thus are in a prime position to regulate 
mechanisms of plasticity at NAc glutamatergic synapses. Dissecting the mechanisms by 
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which DA modulates glutamatergic synaptic strength is complex since dopamine can 
exert divergent effects on cells depending on the DA receptor type activated: D1-class 
(D1, D5: Gs-coupled GPCR) or D2-class (D2, D3, D4: Gi/o-coupled). One mechanism by 
which DA could modulate glutamatergic synaptic transmission is by altering the number, 
function, or trafficking of AMPARs in the synapse. Several studies utilizing cultured 
MSNs have reported that acute activation of DA D1-class receptors increases cell surface 
expression of GluA1-containing AMPARs through PKA-dependent phosphorylation 
(Cepeda et al., 1993; Chao et al., 2002; Mangiavacchi and Wolf, 2004) and potentiates 
AMPAR-mediated currents (André et al., 2010; Price et al., 1999), indicating that D1 
activation can promote the trafficking and insertion of AMPARs at the synapse. 
Conversely, D2 stimulation decreases AMPAR expression levels and reduces AMPAR 
transmission (André et al., 2010; Hernández-Echeagaray et al., 2004; Sun et al., 2005).  
Dopamine D1 and D2 receptor mechanisms therefore appear to oppositely 
regulate AMPAR synaptic strength. However, repeated exposure to exogenous DA, 
modeling the increased synaptic availability of DA induced by cocaine, abolishes the 
ability of D1 stimulation to promote increased AMPAR function (Sun et al., 2008). 
Similarly, PKA-mediated phosphorylation of AMPAR subunits, a necessary step in 
membrane trafficking, is strongly increased in the NAc following acute cocaine exposure 
but only weakly activated following several weeks of cocaine self-administration (Bibb et 
al., 2001; Edwards et al., 2007), indicating that sustained elevations in DA alter the 
normal function of DA receptors to modulate glutamatergic synaptic strength in a time-
sensitive manner. Given the critical role that DA plays in reward-related learning, 
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motivation, and addiction (Kauer and Malenka, 2007; Wheeler and Carelli, 2009), these 
studies highlight a potential role for DA receptors in mediating AMPAR plasticity in the 
NAc modified by cocaine experience. 
 
Modulatory functions of the endocannabinoid system 
The endocannabinoid (eCB) system is another critical neuromodulator of synaptic 
activity and plasticity throughout the brain. eCBs are lipophilic membrane-derived 
molecules, of which anandamide and 2-arachidonoyl glycerol (2-AG) are the most 
abundant and best-characterized eCBs in the CNS. eCBs are synthesized on-demand from 
membrane-derived lipid precursors in response to post-synaptic activation of Gq-coupled 
Group I metabotropic glutamate receptors (mGluRs) or elevations in post-synaptic 
calcium (Castillo et al. 2012). Landmark studies characterizing the eCB system revealed 
that once released from the post-synaptic cell, eCBs diffuse via retrograde action to 
cannabinoid type 1 (CB1) receptors, Gi/o-coupled GPCRs located on pre-synaptic axon 
terminals that suppress neurotransmitter release when activated (Kreitzer and Regehr, 
2001; Wilson and Nicoll, 2001). CB1 receptors are highly expressed at excitatory and 
inhibitory synapses throughout the CNS but are particularly abundant in regions of the 
mesocorticolimbic dopamine system associated with reward, motivation, and cognition, 
including the striatum (Herkenham et al., 1991; Mátyás et al., 2006). Within the striatum, 
eCB signaling has emerged as a dominant mechanism for reducing synaptic strength at 
excitatory synapses through several forms of short-term and long-term synaptic 
depression (Lovinger and Mathur, 2017; Robbe et al., 2003; Zlebnik and Cheer, 2016). 
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The retrograde signaling mechanism of the eCB system provides a “gain control” 
negative feedback loop through which post-synaptic neuronal activity can modify the 
level of synaptic input at afferents onto MSNs, finely adjusting synaptic strength.  
Accumulating evidence indicates that eCB signaling at the CB1 receptor plays a 
central role in modulating reward, motivation, and addiction (Olière et al., 2013; Parsons 
and Hurd, 2015). NAc shell CB1 signaling is necessary for the expression of cocaine-
primed behavioral sensitization, without appearing to play a role in the induction phase of 
sensitization (Filip et al., 2006; Gerdeman et al., 2007; Ramiro-Fuentes and Fernandez-
Espejo, 2011). In studies utilizing the drug self-administration model, CB1 signaling is 
necessary for cocaine- (Xi et al., 2006),  cue- (De Vries et al., 2001), and stress-
potentiated (McReynolds et al., 2016) reinstatement of cocaine seeking following a 
period of abstinence or extinction, without impacting acquisition of drug seeking. 
Additionally, antagonism of NAc CB1 receptors reduces breakpoints under a progressive 
ratio schedule of cocaine seeking (Orio et al., 2009), suggesting that the eCB system 
might mediate increased motivation to seek drug over an extended period of time. These 
studies broadly indicate a pattern whereby CB1 signaling is a critical factor in the 
persistence of cocaine seeking over a protracted period of drug administration and 
subsequent abstinence or extinction, while being minimally engaged by more short-term 
drug exposure paradigms. The ability of the eCB system to selectively alter persistent 
drug-seeking behavior furthermore suggests the modulation of neuroadaptations set in 
place by chronic drug experience, making this system a prime candidate in mediating 
cocaine-evoked alterations in glutamatergic synaptic strength. 
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In this study, the role of dopamine and eCB signaling in cocaine-induced 
depotentiation of glutamatergic synaptic strength in the NAc was investigated, examining 
changes in AMPAR-mediated signaling induced by cocaine experience. As in previous 
studies, we employed an ex vivo cocaine challenge model to allow for pharmacological 
isolation of the cellular signaling mechanisms of NAc synaptic plasticity. 
 
Materials and methods 
Animals   
Adult male (P49-70) C57BL/6 mice (Jackson Laboratories, Bar Harbor, Maine, 
USA) were used. All animals were group-housed in a temperature- and humidity-
controlled environment on a 12 hr light/12 hr dark cycle, with food and water available 
ad libitum. All experiments were approved by the Institutional Animal Care and Use 
Committee at the University of Minnesota. 
 
Behavioral sensitization 
Prior to testing, mice were habituated to experimenter handling, i.p. injections, 
and the testing environment (individual activity boxes, 8.5 x 17.5 x 9 in) over two days. 
On five consecutive testing days, mice were habituated to the testing environment for 30 
minutes (min) before receiving an intraperitoneal injection of either cocaine (15 mg/kg) 
or saline. Mice were immediately placed back into the testing environment, and their 
activity was monitored for 90 min using a video-based tracking system (Any-Maze, 
Stoelting, WI, USA). Animals were returned to their home cages at the end of each 
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testing period. Following the last day of testing, animals remained in their home cages in 
the colony for 10 – 14 days before electrophysiology experiments were performed. To 
determine whether repeated cocaine treatment produced behavioral sensitization, the 
locomotor activity (distance traveled) during the first 30 minutes of the session on Day 1 
and Day 5 was compared, pooling all cocaine-treated animals. A t-test was used to 
confirm a significant difference in locomotor activity between Day 1 and Day 5, 
indicating the development of behavioral sensitization to cocaine. Animals that did not fit 
these criteria were excluded from recording experiments. 
 
Slice electrophysiology 
 Following 10–14 days of abstinence from cocaine treatment, mice were 
anesthetized with isoflurane, decapitated, and the brain rapidly removed. Parasagittal 
slices (240 µm) containing the nucleus accumbens shell were prepared in 2-4°C sucrose-
containing artificial cerebrospinal fluid (ACSF), after which slices rested for at least 30 
min in standard ACSF at room temperature. To assess AMPAR-mediated excitatory 
synaptic transmission, cells were voltage-clamped at -80 mV using an Axon Instruments 
MultiClamp 700A (Molecular Devices, Sunnyvale, CA, USA). Data were filtered at 2 
kHz, digitized at 5 kHz, and collected using custom Igor Pro software (Wavemetrics, 
Lake Oswego, OR, USA). MiniAnalysis software (Synaptosoft, Decatur, GA, USA) was 
used offline to analyze mEPSC amplitude, frequency, rise time, and decay time. To 
determine the rise time and decay time, two exponentials were fit to the rise time or 
decay time of mEPSCs using the MiniAnalysis curve-fitting function, and the time 
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constant was calculated between 10-90% of peak. For a more detailed description of slice 
preparation and recording methods, see Chapter 1. 
 
Ex vivo drug application 
Drugs were prepared in a stock solution and added at the final concentration to the 
ACSF perfusing the slices. A between-cell experimental design was utilized in which 
slices were bathed in the drug or control ACSF prior to recording synaptic activity. 
During these experiments, slices were exposed to one of the following conditions:  
1. No challenge (ACSF only)  
2. Ex vivo cocaine challenge (10 µM; 10 min)  
3. Ex vivo flupenthixol (non-specific dopamine receptor antagonist; 20 µM; 10 min) 
or SR141716A (CB1 antagonist/inverse agonist; 1 µM; 10 min) alone;  
4. Ex vivo flupenthixol or SR141716A alone (10 min) followed by flupenthixol or 
SR141716A in the presence of 10 µM cocaine (10 min);  
5. Ex vivo apomorphine (non-specific dopamine receptor agonist; 1 µM; 10 min) or 
WIN 55,212-2 (CB1 receptor agonist; 1 µM; 20 min) alone.  
Following the timed ex vivo drug exposure(s), the perfusion was switched back to 
standard ACSF for recording. Recordings took place up to 1 hour following ex vivo drug 
exposure. 
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Figure 3.1. Timeline of experimental manipulations. Mice received five once-daily injections 
of cocaine or saline, followed by 10-14 days of abstinence in their home cages. Brain slices were 
prepared following the abstinence period, and cocaine challenge was performed ex vivo: slices 
were exposed to 10 µM cocaine in the perfusing ACSF for 10 minutes, followed by 
electrophysiological recording in standard ACSF. To examine DA receptor signaling, the DA 
antagonist flupenthixol (10 µM) was added to the bath before cocaine challenge, or a DA receptor 
agonist apomorphine (1 µM) was substituted in place of the cocaine challenge. To examine CB1 
signaling, the antagonist SR141716A (1 µM) was added to the bath before cocaine challenge, or 
the agonist WIN 55,212-2 was used in place of cocaine. Recording took place immediately 
following drug challenges. 
 
 
Drugs  
Apomorphine, flupenthixol, SR141716A, and WIN 55,212-2 were purchased 
from Tocris Bioscience (Bristol, United Kingdom). Lidocaine and picrotoxin were 
purchased from Sigma Aldrich (St. Louis, MO, USA). Cocaine was obtained from 
Boynton Health Services Pharmacy (University of Minnesota, Minneapolis, MN, USA). 
Drugs were prepared in a stock solution at 100 – 1000 times the desired concentration 
and added into standard ACSF at the final concentration. SR141716A stock was 
dissolved in DMSO, and WIN 55,212-2 stock was dissolved in ethanol. The final 
concentrations of DMSO or ethanol were <0.01%. 
 
Statistical analysis 
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All data are presented as group mean ± SEM. Statistical significance was assessed 
with a Student’s t-test, one-way ANOVA, or two-way ANOVA using JMP Pro (SAS, 
Cary, NC, USA) and GraphPad Prism (GraphPad Software, La Jolla, CA, USA). Tukey 
HSD post hoc tests were used for pairwise comparisons where appropriate. The threshold 
for significance was p<0.05.  
 
Results 
Dopamine receptor activation is necessary for cocaine-induced synaptic depotentiation. 
In the striatum, dopamine plays a critical role in regulating the induction of 
synaptic plasticity by modulating excitatory synaptic transmission through several 
mechanisms, including modification of post-synaptic neurotransmitter receptors 
(O’Donnell, 2003; Surmeier et al., 2007; Tritsch and Sabatini, 2012). Several studies 
indicate that dopamine receptor activation promotes increased surface expression of MSN 
AMPARs (Snyder et al., 2000; Wolf, 2010). Thus, we hypothesized that dopamine 
receptor activation provoked by cocaine re-exposure might participate in the reversal of 
enhanced AMPAR synaptic transmission in the NAc shell.  
To examine this, we applied the non-specific dopamine antagonist flupenthixol ex 
vivo prior to cocaine challenge to determine whether dopamine receptor activation is 
necessary for the induction of AMPAR synaptic depotentiation. A non-specific dopamine 
receptor antagonist was chosen for these studies, as our goal was to assess AMPAR 
function in NAc MSN subpopulations as a whole, rather than differentiate between 
effects that may selectively occur on MSNs expressing select DA receptor sub-types. As 
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previously demonstrated, abstinence (10-14 d) from repeated cocaine potentiated mEPSC 
amplitude (picoamperes of current, pA), which was reversed by ex vivo cocaine bath 
challenge [figure 3.2B-left: Sal (10.19 ± 0.53, 8 cells/6 animals); Coc (13.09 ± 0.46, 11 
cells/10 animals); Coc-coc (10.04 ± 0.40, 9 cells/6 animals); F(4,37) = 10.39, p<0.0001]. 
Similarly, mEPSC frequency (events per second, Hz) was increased during withdrawal 
from cocaine but reversed by ex vivo cocaine challenge [figure 3.2B-right: Sal (4.08 ± 
0.53); Coc (6.87 ± 0.84); Coc-coc (4.23 ± 0.42); F(4,37) = 4.59, p=0.0041]. However, bath 
application of flupenthixol (20 µM) prior to ex vivo cocaine challenge blocked the 
cocaine-induced reduction in mEPSC amplitude (12.42 ± 0.70) and frequency (6.410 ± 
0.86) (7 cells/4 animals). Exposure to flupenthixol alone had no baseline effects on 
mEPSC amplitude or frequency in saline-treated (amplitude: 10.53 ± 0.89; frequency: 
4.81 ± 0.76, 7 cells/6 animals, data not shown) or cocaine-treated animals (amplitude: 
12.08 ± 0.64; frequency: 5.36 ± 0.67, 6 cells/5 animals, not shown). In addition, there 
were no differences in the rise time kinetics [Sal (3.28 ± 0.14); Coc (3.18 ± 0.08); Coc-
coc (3.61 ± 0.19); Coc-Flp-coc (3.31 ± 0.13); F(4,34)=1.70, p=0.17, not shown] or decay 
time kinetics [Sal (3.62 ± 0.22); Coc (3.89 ± 0.16); Coc-coc (3.79 ± 0.27); Coc-Flp-coc 
(4.17 ± 0.23); F(4,34)=0.80, p=0.53, not shown] of AMPAR mEPSCs evident among the 
groups. 
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Dopamine receptor activation is sufficient to drive depotentiation of AMPAR synaptic 
transmission in the NAc shell. 
Given that activation of DA receptors has been shown to mediate the induction of 
striatal LTD (Calabresi et al., 2007; Kreitzer and Malenka, 2005), we next investigated 
whether dopamine receptor activation is sufficient to drive reductions in AMPAR 
signaling produced by cocaine and subsequent abstinence. Ex vivo application of the non-
specific dopamine receptor agonist apomorphine (1 µM) reduced mEPSC amplitude 
(figure 3.2B-left; 9.33 ± 0.40) and frequency (figure 3.2B-right; 3.61 ± 0.36) (6 cells/4 
animals) compared to cocaine + no challenge controls. Apomorphine application in saline 
animals had no effect on baseline mEPSC amplitude (9.62 ± 0.63) or frequency (3.37 ± 
0.61) (6 cells/4 animals). AMPAR mEPSC rise time (3.56 ± 0.21) and decay time 
kinetics (3.91 ± 0.26) were unchanged by apomorphine. Taken together, these data 
demonstrate that dopamine receptor activation is both necessary and sufficient for 
AMPAR synaptic depotentiation elicited by re-exposure to cocaine, demonstrating a 
central role for dopamine receptors in mediating this form of plasticity.  
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Figure 3.2. Dopamine receptor activation is necessary for cocaine-induced depotentiation of 
NAc shell AMPAR signaling. (A) Representative mEPSC current traces from NAc shell 
neurons. (B) Mean mEPSC amplitude and frequency in the NAc shell from saline (Sal), cocaine + 
no challenge (Coc), cocaine + cocaine challenge (Coc-coc), cocaine + flupenthixol/cocaine (Coc-
Flp-Coc), cocaine + apomorphine (Coc-Apo). (C) Cumulative probability distributions of mEPSC 
amplitude and inter-event interval of treatment groups. All data are presented as mean ± SEM. 
*p<0.05 vs. Coc, ** p<0.01 vs. Coc, *** p<0.001 vs Coc; # p<0.05 vs. Coc-Flp-coc, ## p<0.01 
vs. Coc-Flp-coc. 
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CB1 receptor activation is necessary for cocaine-induced synaptic depotentiation. 
Within the NAc, endogenous cannabinoids play a central role in modulating 
glutamatergic synaptic transmission (Lüscher and Huber, 2010; Robbe et al., 2002). 
Located predominantly on axon terminals contacting MSNs, activation of CB1 receptors 
promotes suppression of neurotransmitter release following activation of post-synaptic 
signaling mechanisms (Robbe et al., 2001; Hoffman and Lupica, 2001; Robbe et al., 
2003). To test whether CB1 receptor activation mediates cocaine-induced reductions in 
AMPAR synaptic transmission, we bath applied the CB1 antagonist/inverse agonist 
SR141716A during an ex vivo cocaine challenge. While bath application of SR141716A 
(1 µM) in the presence of ex vivo cocaine produced only a modest blockade of the 
cocaine-induced reductions in mEPSC amplitude (figure 3.3B-right; Sal (10.32 ± 0.35, 8 
cells/7 animals); Coc (14.17 ± 0.59, 12 cells/9 animals); Coc-coc (9.76 ± 0.52, 10 cells/6 
animals); Coc-SR-Coc (11.89 ± 2.47, 15 cells/10 animals); F(4,48)=11.31, p<0.0001), it 
robustly blocked the decrease in mEPSC frequency (figure 3.3B-right; Sal (3.50 ± 0.38); 
Coc (6.73 ± 0.82); Coc-coc (3.26 ± 0.28); Coc-SR-coc (6.36 ± 0.62); F(4,48) = 6.73, 
p=0.0002). No changes in AMPAR rise time kinetics [Sal (3.75 ± 0.17); Coc (3.30 ± 
0.09); Coc-coc (3.53 ± 0.17); Coc-SR-coc (3.18 ± 0.16), not shown] or decay time 
kinetics [Sal (5.10 ± 0.32); Coc (4.36 ± 0.23); Coc-coc (4.33 ± 0.27); Coc-SR-coc (4.01 ± 
0.26), not shown] were observed. Bath application of SR141716A produced a slight 
elevation of baseline mEPSC frequency in both saline and cocaine pre-treated animals, 
but this effect was not significant [Sal-SR (5.09 ± 1.12, 6 cells/4 animals); Coc-SR (7.91 
± 1.36, 6 cells/5 animals), data not shown]. 
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Activation of NAc CB1 receptors promotes AMPAR synaptic depotentiation. 
We next asked whether activation of CB1 receptors is sufficient to induce 
synaptic depotentiation in the NAc shell. While several studies have reported that 
activation of CB1 receptors in the striatum is sufficient to induce eCB-mediated LTD 
(Kreitzer and Malenka, 2005; Robbe et al., 2001), it is not clear whether these 
mechanisms remain intact or are altered following cocaine exposure. To investigate this, 
we substituted the ex vivo cocaine challenge with bath application of the CB1 receptor 
agonist WIN 55,212-2 ex vivo. Application of WIN 55,212-2 (1 µM) was sufficient to 
induce depotentiation of mEPSC amplitude (figure 3.3B-left; 9.69 ± 0.25, 8 cells/4 
animals) and frequency (figure 3.3B-right; 3.99 ± 0.73) in slices from animals abstinent 
from cocaine, without altering basal mEPSC amplitude (10.38 ± 0.72) or frequency (3.38 
± 0.51) in saline-treated animals (7 cells/3 animals). No changes in mEPSC rise time 
(3.72 ± 0.23) or decay time (4.76 ± 0.27) kinetics were detected. Our results demonstrate 
that activating CB1 receptors during abstinence from repeated cocaine is sufficient to 
depotentiate AMPAR-mediated synaptic transmission in the NAc. 
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Figure 3.3 CB1 receptor activation is necessary for cocaine-induced synaptic depotentiation. 
(A) Representative mEPSC current traces from NAc shell neurons. (B) Mean mEPSC amplitude 
and frequency in the NAc shell from saline (Sal), cocaine + no challenge (Coc), cocaine + 
cocaine challenge (Coc-coc), cocaine + SR141716A/cocaine (Coc-SR-Coc), cocaine + Win 
55,212-2 (Coc-Win). (C) Cumulative probability distributions of mEPSC amplitude and inter-
event interval of treatment groups. All data are presented as mean ± SEM. *p<0.05 vs. Coc, ** 
p<0.01 vs. Coc, *** p<0.001 vs Coc, **** p<0.0001 vs. Coc; # p<0.05 vs. Coc-SR-coc, ## 
p<0.01 vs. Coc-SR-coc. 
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Discussion 
Dopamine modulation of excitatory synaptic transmission 
Dopamine has been well-demonstrated to play an important role in motivated 
behavior and plasticity within the striatum. Exposure to cocaine in vivo (Di Chiara and 
Imperato, 1988) and ex vivo (Hoffmann et al., 2012; Kelly and Wightman, 1987) 
increases the synaptic availability of dopamine within the NAc. Dopamine action at 
receptors located both on pre-synaptic axon terminals and on MSNs in the NAc 
modulates the activity of cells and furthermore gates the induction of plasticity at these 
synapses by influencing synaptic integration, neurotransmitter release properties, 
trafficking of post-synaptic receptors, and membrane excitability through complex 
intercellular mechanisms (Tritsch and Sabatini, 2012). Activation of DA receptors thus 
acts to “tune” cells to glutamatergic input, thereby altering the dynamics of circuits 
mediating reward-related behavior. However, DA modulation of excitatory synaptic 
strength is greatly altered by cocaine experience. While increased dopamine release 
elicited by natural rewards is tightly controlled by synaptic re-uptake mechanisms, 
cocaine and other psychostimulants elicit large increases in extracellular dopamine that 
are unregulated due to inhibition of re-uptake transport. Thus, cocaine exposure produces 
persistent activation of DA receptors, which is likely to have sustained, inappropriate 
effects on modulation of glutamatergic transmission, such as altered AMPAR trafficking 
or desensitization of receptors (Wolf, 2010). The outcome of such intense dopamine 
stimulation produces strong associative learning, motivating drug-seeking behavior. 
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Cocaine-induced alterations in dopamine receptor signaling mechanisms 
Evidence suggests that long-term exposure to cocaine also alters dopamine 
receptor signaling mechanisms. One way that cocaine disrupts normal dopamine 
signaling mechanisms is through disrupting the balance between D1 and D2 receptor 
activity (Walters et al, 1987). These two receptor sub-types mediate opposing effects on 
adenylyl cyclase stimulation, activation of PKA, and subsequent triggering of 
downstream cellular effectors, with D1 receptors generally activating this pathway and 
D2 receptors suppressing it. Following chronic cocaine exposure, the equilibrium appears 
to shift toward D1 activation: D1 receptors (Anderson and Pierce, 2005) and cAMP 
production (Terwilliger et al., 1991) are upregulated, while expression of Gi/o-coupled 
proteins is significantly reduced (Nestler et al., 1990; Terwilliger et al., 1991). At the 
same time, a number of studies have observed that while D1 receptor signaling is able to 
modulate PKA-dependent trafficking of AMPARs acutely, repeated dopamine or cocaine 
exposure abolishes this function (Sun et al., 2008), likely due to a reduction in overall 
PKA activity (Bibb et al., 2001; Edwards et al., 2007). Prolonged D1 stimulation may 
therefore produce “tolerance” of these signaling mechanisms at the intercellular level, 
possibly due to desensitization or adaptations of D1 receptor signaling mechanisms. 
Thus, up-regulated D1 receptors might reflect compensatory mechanisms balancing out 
the effects of chronic cocaine exposure. 
 An alternative view is that upregulated D1 receptor signaling mechanisms prime 
synapses to respond to fluctuations in glutamate signaling (Wolf, 2010). Indeed, D1 
receptor stimulation has been well-demonstrated to promote AMPAR trafficking through 
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PKA- and PKC-dependent phosphorylation signaling mechanisms (Tritsch and Sabatini, 
2012). Rapid reversal of potentiated AMPAR signaling by cocaine re-exposure might 
reflect engagement of D1 receptors that promote internalization of AMPARs. Consistent 
with this, one report demonstrated that blocking clathrin-dependent AMPAR endocytosis 
with a synthetic peptide prevents the induction of LTD in the NAc during abstinence 
from chronic amphetamine (Brebner et al., 2005). Similarly, blocking PKC-mediated 
phosphorylation of AMPARs attenuates reinstatement of cocaine seeking behavior 
(Famous et al., 2008). While more research is needed to characterize the mechanisms 
underlying rapid internalization of AMPARs, activation of dopamine receptors may 
contribute to trafficking processes that serve to promote a rapid reduction in AMPAR 
signaling following cocaine re-exposure. 
 
Ex vivo cocaine engages dopamine signaling mechanisms  
Here, we found that activation of DA receptors with the agonist apomorphine 
produced robust depotentiation of AMPAR-mediated synaptic strength, while blocking 
receptors with the antagonist flupenthixol prevented the ex vivo cocaine-induced 
suppression of glutamatergic synaptic strength. The ability of DA receptor signaling to 
bidirectionally modulate synaptic strength demonstrates that transient activation of 
endogenous DA signaling mechanisms is both necessary and sufficient to rapidly 
depotentiate elevated AMPAR synaptic transmission in the NAc shell. Notably, it is 
unclear exactly how cocaine augments endogenous DA in our ex vivo conditions, given 
that minimal dopamine cell firing would be expected to occur in an ex vivo slice 
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preparation. One hypothesis is that spontaneously-occurring DA release at terminals in 
the NAc could be enhanced by cocaine. Spontaneous DA transients mediated by 
individual exocytotic release events have been observed in striatal slice preparations in a 
number of reports (Beckstead et al., 2004; Gantz et al., 2013; Zhou et al., 2001). Since 
spontaneous transients occur at low frequencies and amplitudes, they may be normally 
undetectable in control conditions. However, acute ex vivo cocaine has been shown to 
increase the frequency and amplitude of dopamine transients in the NAc through 
activation of nicotinic acetylcholine receptors, increasing the ability to detect these events 
(Yorgason et al., 2017)—indicating a mechanism through which ex vivo cocaine might 
produce elevated synaptic dopamine in slice. 
 
Receptor type- and cell type-specific mechanisms of dopamine function 
The effects of dopamine receptor activity on AMPAR signaling in the NAc are 
likely to be varied and complex, given that dopamine receptor activation is capable of 
bidirectionally modifying excitatory synaptic strength depending on the dopamine 
receptor subtype and location, MSN cell subtype, level of synaptic activity, as well as 
previous drug experience (Tritsch and Sabatini, 2012; Wang et al., 2012). Because data 
from this study and previous work (Jedynak et al., 2016; Kourrich et al., 2007; Rothwell 
et al., 2011) were collected from pooled populations of MSNs, it is difficult to determine 
not only the DA receptor subtype involved but also the exact locus of the cocaine-
dependent suppression of excitatory signaling. Activation of DA D1 and D2 receptors in 
the NAc has been shown to be necessary both for the expression of behavioral 
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sensitization (Henry et al., 1998; Mattingly et al., 1994) and reinstatement of cocaine 
seeking (Anderson et al., 2005, 2003; Schmidt et al., 2006), indicating a role for both 
receptor types in cocaine-related behavior and NAc function following drug re-exposure. 
However, a significant body of literature indicates that cocaine-related synaptic plasticity 
occurs preferentially at D1-expressing MSNs of the NAc (MacAskill et al., 2014; Pascoli 
et al., 2014, 2011; Terrier et al., 2016). Depotentiation of AMPAR signaling might 
therefore reflect a reversal of AMPA signaling specifically at D1-MSN synapses 
previously potentiated by cocaine experience.  
 
CB1 receptors mediate reversal of enhanced AMPAR transmission in the NAc 
 Within the striatum, eCB signaling is a critical regulator of synaptic activity and 
plasticity, facilitating synaptic depression at glutamatergic synapses on MSNs through 
CB1 receptor-mediated suppression of excitatory transmission (Gerdeman et al., 2002; 
Kreitzer and Malenka, 2007; Robbe et al., 2002). Furthermore, accumulating evidence 
indicates a critical role for eCB signaling in reward-related behavior and facilitation of 
excitatory synaptic plasticity in the striatum (Wiskerke et al., 2008; Zlebnik and Cheer, 
2016). Given the fundamental role that eCBs play in dampening excitatory signaling 
throughout the striatum, we hypothesized that eCB signaling mechanisms might be 
engaged by cocaine re-exposure to promote depotentiation of synaptic strength in the 
NAc shell. While evidence of the impact of repeated cocaine on eCB-mediated signaling 
and synaptic plasticity in the NAc is still relatively limited, several studies previously 
suggested that eCB-mediated plasticity in the striatum is impaired by acute cocaine  
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(Fourgeaud et al., 2004; Grueter et al., 2010). However, more recent work demonstrated 
that CB1 signaling remains functionally intact following repeated cocaine  (McCutcheon 
et al., 2011; Ortinski et al., 2012). In the present study, we define a specific role for CB1 
receptors in reversing enhanced NAc AMPAR transmission during abstinence from 
cocaine. We observed that application of the CB1 receptor antagonist/inverse agonist 
SR141716A prevented the cocaine-induced reduction in mEPSC frequency while 
partially rescuing the challenge-induced reduction in mEPSC amplitude, indicating 
stronger modulation of pre-synaptic release properties. Additionally, we found that 
activation of CB1 receptors with the agonist WIN 55,212-2 was sufficient to depotentiate 
both mEPSC amplitude and frequency. These findings confirm that CB1 signaling 
remains functionally intact following repeated cocaine and is capable of modulating 
mechanisms of glutamatergic synaptic plasticity in the NAc shell. 
To our knowledge, our data are the first to report that CB1 signaling modifies 
post-synaptic AMPAR signaling during protracted abstinence from cocaine. An issue of 
contention regarding eCB-mediated synaptic plasticity has been whether activation of 
CB1 receptors alone is sufficient to induce depression (i.e. eCB-LTD) (Kreitzer and 
Malenka, 2005). The ability of the CB1 agonist WIN 55,212-2 to suppress both mEPSC 
frequency and amplitude in the present study is somewhat surprising given the pre-
synaptic localization of these receptors on glutamatergic afferents in the NAc. However, 
there is some evidence that WIN 55,212-2 is capable of robustly depressing measures of 
pre-synaptic and post-synaptic glutamatergic transmission in the striatum. One report 
observed that activation of CB1 receptors with WIN 55,212-2 (using the same 
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concentration as this study) is sufficient to depress electrically-evoked EPSCs in striatal 
MSNs, an effect that did not require post-synaptic GPCR signaling (Kreitzer and 
Malenka, 2005). Similarly, CB1 activation with WIN 55,212-2 depressed both mEPSC 
amplitude and frequency in the NAc, indicating post-synaptic modulation of AMPAR 
currents (Hoffman and Lupica, 2001). Additionally, endogenous and exogenous 
cannabinoid ligands have been shown to alter post-synaptic signaling properties by 
modulating several ionic conductances (Deadwyler et al., 1995; Mackie et al., 1995; 
Schweitzer, 2000) or other non-CB1 receptors located on the post-synaptic membrane 
including TRPV1 receptors, peroxisome proliferator-activated receptors (PPARs), and G-
protein receptor 55 (GPR55) and 119 (GPR119) (Grueter et al., 2010; Parsons and Hurd, 
2015). However, it is important to note that the majority of these studies examined CB1-
mediated synaptic depression under basal (non-drug) conditions; it is still relatively 
unknown how CB1 signaling engages and potentially alters cellular mechanisms of 
plasticity at synapses altered by chronic cocaine exposure. It seems likely that the 
mechanisms required to suppress excitatory signaling would be different at synapses 
under altered glutamate homeostasis, as is the case following chronic cocaine exposure 
(Knackstedt and Kalivas, 2009). Additional studies will be needed to elucidate how CB1 
receptor activation is capable of broadly modulating both pre- and post-synaptic 
glutamatergic transmission in the NAc following experience with cocaine. 
We observed that application of the CB1 antagonist SR141716A caused a 
moderate (but not significant) elevation in AMPAR transmission in MSNs from mice 
pre-treated with saline or cocaine but not challenged with cocaine ex vivo. This could be 
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evidence for SR141716A acting as an inverse agonist, relieving CB1-mediated inhibition 
of glutamate release exerted by reducing the activity of constitutively-active CB1 
receptors. Alternatively, this could indicate antagonism of CB1 activity through 
suppression of tonic eCB signaling. While early studies characterized SR141716A as an 
inverse agonist (Bouaboula et al., 1997; Maneuf and Brotchie, 1997; Rinaldi-Carmona et 
al., 1994), these studies were conducted in heterologous expression systems or 
dissociated cell cultures—reduced systems where tonic levels of eCBs are extremely low 
compared to physiological brain levels (Pan et al., 2008; Pertwee, 2005). Furthermore, 
studies examining glutamatergic synaptic plasticity in the striatum have found that 
SR141716A does not consistently affect basal synaptic transmission (Auclair et al., 2000; 
Huang et al., 2001) and, more importantly, fully reverses WIN 55,212-2-mediated 
synaptic depression (Gerdeman and Lovinger, 2001; Hoffman and Lupica, 2001; Robbe 
et al., 2001, 2002). Therefore, it seems likely that the inverse agonism effects of 
SR141716A under these experimental conditions are minimal at best, and that this 
compound is acting chiefly as an antagonist. 
 
Potential cellular mechanisms of eCB-mediated synaptic depotentiation 
Given that striatal CB1 signaling plays a central role in synaptic depression at 
glutamatergic synapses, our data suggest that cocaine re-exposure during abstinence 
engages similar CB1 signaling mechanisms that promote a reduction in glutamatergic 
synaptic transmission at NAc MSN synapses. CB1 signaling in the NAc therefore might 
participate in reducing excitatory synaptic strength by interacting with a number of 
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potential cellular mechanisms. A substantial body of evidence has demonstrated that 
eCB-mediated depression of glutamatergic transmission in the striatum commonly 
requires activation of Group I mGluRs (mGluR1 and mGluR5) (Lüscher and Huber, 
2010). Activation of post-synaptic mGluR1/5 on NAc MSNs promotes the release of 
eCBs, which activate pre-synaptic CB1 receptors to decrease neurotransmitter release 
probability and promote synaptic depression (Castillo et al., 2012; Robbe et al., 2002). 
Enhanced glutamatergic synaptic transmission in the NAc elicited by re-exposure to 
cocaine (McFarland et al., 2003; Park et al., 2002; Xi et al., 2006) may therefore activate 
mGluR1/5 and initiate eCB signaling, promoting a reduction in synaptic strength. 
Previously, our lab demonstrated that mGluR5 signaling in the NAc shell is necessary for 
cocaine-induced AMPAR synaptic depotentiation (Chapter 1). These findings showing 
that synaptic depotentiation requires CB1 receptor activity in the NAc shell could reflect 
serial activation of mGluR5 and CB1 receptors that participate in reducing glutamatergic 
synaptic transmission in the NAc shell following cocaine re-exposure. 
In addition, dopamine D2 receptors have been shown to cooperate with Group I 
mGluRs to promote eCB signaling and excitatory synaptic depression in the striatum  
(Kreitzer and Malenka, 2005; Yin and Lovinger, 2006). Glutamatergic synapses onto D2 
receptor-expressing MSNs in the striatum preferentially express eCB-mediated LTD 
compared to D1-MSNs (Grueter et al., 2010; Kreitzer and Malenka, 2007), and several 
studies have reported a requirement for D2 receptor activation in striatal eCB-LTD  
(Kreitzer and Malenka, 2007; Shen et al., 2008; Wang et al., 2006). A potential 
explanation for this phenomenon is that D2 receptor activation facilitates eCB production 
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in the striatum (Centonze et al., 2004; Giuffrida et al., 1999; Patel et al., 2003; Wang et 
al., 2006), and may cooperate with Group I mGluRs to increase synthesis of eCBs to 
promote synaptic depression. Increased synaptic availability of both glutamate and 
dopamine due to cocaine re-exposure may therefore activate mGluR5 and D2 receptors 
that work together to dampen excitatory synaptic strength. While additional studies are 
needed to determine the cell type- and receptor type-specific mechanisms by which 
cocaine re-exposure engages both dopamine and eCB signaling mechanisms to modify 
glutamatergic synaptic plasticity, our findings demonstrate that the eCB system, a central 
mechanism mediating synaptic depression in the striatum, participates in attenuating 
potentiated AMPAR synaptic transmission during abstinence from cocaine. Given that 
increasing clinical evidence suggests that an interaction between both the dopamine and 
eCB systems is involved in the pathophysiology of numerous disorders involving the 
striatum (García et al., 2016; Kuepper et al., 2010; Parolaro and Rubino, 2008; Pisani et 
al., 2011), understanding the complex interactions between these two systems may be 
critical in developing future therapeutic strategies for relapse. 
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Chapter 4: Cocaine-evoked synaptic plasticity is MSN cell type-specific 
and is modulated by distinct receptor types 
 
Introduction 
 In the striatum, two distinct MSN populations may be distinguished based on their 
selective expression of dopamine D1 receptors (D1-MSNs) or dopamine D2 receptors 
(D2-MSNs). Furthermore, these cell populations differ in their downstream projection 
targets. While D1-MSNs project directly to the midbrain (“direct pathway”), D2-MSNs 
take a multi-synaptic route through pallidal nuclei before synapsing on midbrain targets 
(“indirect pathway”). Strictly in terms of motor output, D1-MSNs facilitate activation of 
motor systems while D2-MSNs suppress output. Given the coupling of differential 
dopamine receptors to these cell types as well as their divergent projections to 
downstream motor circuitry governing behavior, recent literature in the field has sought 
to characterize how cocaine-induced adaptations at synapses on specific MSN cell sub-
types might underlie long-lasting relapse vulnerability.  
Emerging evidence demonstrates that D1- and D2-MSNs mediate distinct, and 
often opposing, roles for reward-related learning and reinforcement. For example, 
optogenetic stimulation of D1-MSNs in vivo produces reinforcement learning in mice, 
while activation of D2-MSNs suppresses behavior (Kravitz et al., 2012). In addiction-
related studies, D1-MSNs seem to play a more dominant role in producing the rewarding 
and reinforcing effects of drugs of abuse, with more robust molecular, cellular, and 
synaptic alterations occurring in D1-MSNs (Lobo and Nestler, 2011). In a cocaine 
conditioned place preference paradigm, activation of D1-MSNs in the NAc enhances the 
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rewarding effects of cocaine, while D2-MSN stimulation suppresses reward (Lobo et al., 
2010), an effect that involves cellular signaling mechanisms distinct between the two cell 
sub-types. 
Numerous studies have demonstrated that cocaine-induced changes in 
glutamatergic synaptic strength occur almost exclusively at D1-MSN synapses (Kim et 
al., 2011; MacAskill et al., 2014; Terrier et al., 2016; Pascoli et al., 2011, 2014), 
suggesting that D1-MSNs mediate persistent excitatory plasticity induced by repeated or 
chronic drug exposure. However, it is not known whether reductions in enhanced 
AMPAR transmission elicited by renewed cocaine exposure occur exclusively at 
synapses on a particular MSN sub-type. Furthermore, the cellular mechanisms of 
plasticity at synapses on D1- and D2-MSNs have not been elucidated. The purpose of the 
following experiments therefore was two-fold: 1) Characterize cocaine-induced AMPAR 
plasticity in specific MSN sub-types in the NAc shell; 2) Investigate cellular mechanisms 
mediating AMPAR plasticity at specific MSN synapses in the NAc shell. 
 
Materials and methods 
Animals   
Adult male and female mice (P48-60) were heterozygous BAC transgenic mice, 
in which expression of the fluorescent proteins tdTomato and eGFP were driven by D1 
(drd1a-tdtomato) or D2 (drd2-eGFP) dopamine receptors, respectively. All animals were 
group-housed in a temperature- and humidity-controlled environment on a 12 hr light/12 
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hr dark cycle, with food and water available ad libitum. All experiments were approved 
by the Institutional Animal Care and Use Committee at the University of Minnesota. 
 
Behavioral sensitization 
Prior to testing, mice were habituated to experimenter handling, i.p. injections, 
and the testing environment (individual activity boxes, 8.5 x 17.5 x 9 in) over two days. 
On five consecutive testing days, mice were habituated to the testing environment for 30 
minutes (min) before receiving an intraperitoneal injection of either cocaine (15 mg/kg) 
or saline. Mice were immediately placed back into the testing environment, and their 
activity was monitored for 90 min using a video-based tracking system (Any-Maze, 
Stoelting, WI, USA). Animals were returned to their home cages at the end of each 
testing period. Following the last day of testing, animals remained in their home cages in 
the colony for 10 – 14 days before electrophysiology experiments were performed. To 
determine whether repeated cocaine treatment produced behavioral sensitization, the 
locomotor activity (distance traveled) during the first 30 minutes of the session on Day 1 
and Day 5 was compared, pooling all cocaine-treated animals. A t-test was used to 
confirm a significant difference in locomotor activity between Day 1 and Day 5, 
indicating the development of behavioral sensitization to cocaine. Animals that did not fit 
these criteria were excluded from recording experiments. 
 
2.3 Slice electrophysiology 
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 Following 10–14 days of abstinence from cocaine treatment, mice were 
anesthetized with isoflurane, decapitated, and the brain rapidly removed. Parasagittal 
slices (240 µm) containing the nucleus accumbens shell were prepared in 2-4°C sucrose-
containing artificial cerebrospinal fluid (ACSF), after which slices rested for at least 30 
min in standard ACSF at room temperature. To assess AMPAR-mediated excitatory 
synaptic transmission, cells were voltage-clamped at -80 mV using an Axon Instruments 
MultiClamp 700A (Molecular Devices, Sunnyvale, CA, USA). Data were filtered at 2 
kHz, digitized at 5 kHz, and collected using custom Igor Pro software (Wavemetrics, 
Lake Oswego, OR, USA). MiniAnalysis software (Synaptosoft, Decatur, GA, USA) was 
used offline to analyze mEPSC amplitude and frequency. For a more detailed description 
of slice preparation and recording methods, see Chapter 1. 
 
2.4 Ex vivo drug application 
Drugs were prepared in a stock solution and added at the final concentration to the 
ACSF perfusing the slices. A between-cell experimental design was utilized in which 
slices were bathed in the drug or control ACSF prior to recording synaptic activity. 
During these experiments, slices were exposed to one of the following conditions:  
1. No challenge (exposure to ACSF only)  
2. Ex vivo cocaine challenge (10 µM; 10 min) 
3. Ex vivo SCH23390 (D1 antagonist; 3µM) or sulpiride (D2 antagonist; 10 µM) 
alone (10 min) + in the presence of 10 µM cocaine (10 min) 
4. Ex vivo SKF81297 (D1 agonist; 20 µM) or quinpirole (D2 agonist; 10 µM) alone 
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5. Ex vivo SR141716A (CB1 antagonist, 1µM) alone (10 min) + in the presence of 
10 µM 
6. Ex vivo SR141716A (CB1 antagonist; 1µM) alone (10 min) + in the presence of 
SKF81297 or quinpirole (D1 or D2 agonist) 
Following the timed ex vivo drug exposure(s), the perfusion was switched back to 
standard ACSF for recording. Recordings took place up to 1 hour following ex vivo drug 
exposure. 
 
Figure 4.1. Timeline of experimental manipulations. Mice received five once-daily injections 
of cocaine or saline, followed by 10-14 days of abstinence in their home cages. To characterize 
cocaine-induced synaptic depotentiation in specific MSNs, brain slices were prepared following 
abstinence and bath applied with ex vivo cocaine (10 µM). Next, to study the role of specific 
dopamine receptors on MSNs, a D1 or D2 antagonist (SCH23390 or sulpiride) was added to the 
bath prior to cocaine challenge; or, a D1 or D2 agonist (SKF 81297; quinpirole) was substituted 
in place of cocaine. Lastly, to examine DA-CB1 signaling interactions, slices were first exposed 
to a CB1 antagonist (SR141716A) prior to cocaine challenge; or, slices were exposed to the CB1 
antagonist prior to incubation in the D1 or D2 agonist. 
 
 
2.5 Drugs  
SCH23390, SKF81297, sulpiride, quinpirole, and SR141716A were purchased 
from Tocris Bioscience (Bristol, United Kingdom). Lidocaine and picrotoxin were 
purchased from Sigma Aldrich (St. Louis, MO, USA). Cocaine was obtained from 
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Boynton Health Services Pharmacy (University of Minnesota, Minneapolis, MN, USA). 
Drugs were prepared in a stock solution at 100 – 1000 times the desired concentration 
and added into standard ACSF at the final concentration. SR141716A stock was 
dissolved in DMSO, with the final concentrations of DMSO <0.01%. 
 
2.5 Statistical analysis 
All data are presented as group mean ± SEM. Statistical significance was assessed 
with a Student’s t-test, one-way ANOVA, or two-way ANOVA using JMP Pro (SAS, 
Cary, NC, USA) and GraphPad Prism (GraphPad Software, La Jolla, CA, USA). Tukey 
HSD post hoc tests were used for pairwise comparisons where appropriate. The threshold 
for significance was p<0.05.  
 
Results 
Cocaine-induced changes in NAc shell AMPAR synaptic strength are MSN type-specific. 
In the NAc, MSNs may be segregated based on their selective expression of 
dopamine D1-type receptor (D1-MSNs) or D2-type receptor (D2-MSN). These distinct 
cell subpopulations project to different downstream targets and have been shown to 
oppositely regulate reward-related behavior (Lobo and Nestler, 2011). Furthermore, 
plasticity at excitatory synapses in the NAc is differentially altered by experience with 
cocaine. Several studies have demonstrated that cocaine-induced changes in 
glutamatergic signaling occur almost exclusively at D1-MSN synapses (Kim et al., 2011; 
Lobo and Nestler, 2011; Pascoli et al., 2011; Terrier et al., 2016). However, while these 
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studies characterized alterations in synaptic transmission that occur following repeated or 
chronic cocaine administration, it is not yet clear whether subsequent cocaine re-exposure 
during abstinence reduces AMPAR signaling in the NAc in a cell type-specific manner. 
To investigate cell-type specific synaptic depotentiation, we performed recordings of 
mEPSCs following cocaine ex vivo challenge during abstinence from cocaine (10-14 
days). We found that in D1-MSNs, abstinence from repeated cocaine potentiated mEPSC 
amplitude (picoamperes of current, pA), which was reversed by ex vivo cocaine challenge 
[figure 4.2C; Sal (9.93 ± 0.37, 7 cells/5 animals); Coc (14.60 ± 1.14, 8 cells/6 animals); 
Coc-coc (9.60 ± 30, 7 cells/6 animals); F2,20=12.37, p=0.0003]. Similarly, mEPSC 
frequency (events per second, hz) was increased during abstinence but reversed by ex 
vivo cocaine [figure 4.2C; Sal (3.59 ± 0.75); Coc (8.57 ± 1.28); Coc-coc (2.47 ± 0.20); 
F2,20=12.08, p=0.0004]. However, cocaine re-exposure had no effect on mEPSC 
amplitude in D2-MSNs [figure 4.2D; Sal (10.69 ±84, 4 cells/3 animals); Coc (9.74 ± 
0.55, 9 cells/8 animals); Coc-coc (10.73 ± 0.52, 8 cells/7 animals); F2,19=0.96; p=0.4013]. 
Interestingly, cocaine challenge produced a modest increase in mEPSC frequency in D2-
MSNs relative to saline treated animals [Sal (2.78 ± 0.07); Coc (3.78 ± 0.39); Coc-coc 
(5.48 ± 0.80); F2,19=4.022, p=0.035], suggesting modulation of pre-synaptic mechanisms 
of plasticity in D2-MSNs.  
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Figure 4.2. Cocaine-induced changes in NAc shell AMPAR synaptic strength are MSN type-
specific. (A,B) Representative mEPSC current traces from NAc shell D1-MSNs and D2-MSNs. 
(C) Mean mEPSC amplitude and frequency in NAc shell D1-MSNs from saline + no challenge 
(Sal), cocaine + no challenge (Coc), and cocaine + ex vivo cocaine challenge (Coc). (D) Mean 
mEPSC amplitude and frequency in NAc shell D2-MSNs from saline + no challenge (Sal), 
cocaine + no challenge (Coc), and cocaine + ex vivo cocaine challenge (Coc). (E,G) Cumulative 
probability distributions of mEPSC amplitude and inter-event interval in D1-MSNs from saline + 
no challenge (Sal), cocaine + no challenge (Coc), cocaine + ex vivo cocaine challenge (Coc-coc). 
(F, H) Cumulative probability distributions of mEPSC amplitude and inter-event interval in D2-
MSNs from saline + no challenge (Sal), cocaine + no challenge (Coc), cocaine + ex vivo cocaine 
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challenge (Coc-coc). All data are presented as mean ± SEM. * p<0.05 vs. Coc, ** p<0.01 vs Coc, 
***p<0.001 vs. Coc; # p<0.05 vs. Coc-coc. 
 
Cell type-specific bidirectional plasticity in the NAc shell is differentially modulated by 
dopamine receptors. 
Next, we asked whether specific dopamine receptors on D1-MSNs and D2-MSNs 
mediate AMPAR synaptic depotentiation. A major effect of cocaine is to elevate synaptic 
DA levels, leading to activation of DA receptors. DA receptor activity has been shown to 
alter AMPAR signaling at glutamatergic inputs on NAc MSNs (Calabresi et al., 2007; 
Wolf and Ferrario, 2010). Notably, D1 receptors are metabotropic receptors that promote 
increased production of cAMP and PKA phosphorylation through their coupling to Gs 
proteins, and have been demonstrated to modify the trafficking of AMPARs at the 
synapse through phosphorylation of AMPAR subunits (Chao et al., 2002; Mangiavacchi 
and Wolf, 2004) . However, it is not clear how D1 receptor activity modulates changes in 
AMPAR synaptic transmission following cocaine experience. Furthermore, D2 receptors 
have been shown to reduce AMPAR-transmission in basal conditions (André et al, 2010; 
Hernández-Echeagaray et al, 2004) and following cocaine challenge (Ferrario et al., 
2011), raising the possibility that D2 activation might mediate an overall reduction in 
AMPAR synaptic strength following cocaine re-exposure. Bath application of the D1 
receptor-specific antagonist SCH23390 (3 µM) prior to ex vivo cocaine challenge blocked 
the induction of the depotentiation of mEPSC amplitude in D1-MSNs (figure 4.3C; 
14.44 ± 0.90, 7 cells/6 animals; F4,30=9.26, p<0.0001) and frequency (figure 4.3C; 5.66 ± 
1.39; F4,30=8.85, p<0.0001), while sulpiride (D2 antagonist; 10 µM) had no effect on 
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mEPSC amplitude (figure 4.3D; 9.88 ± 0.36, 4 cells/4 animals; p=0.09) or frequency 
(figure 4.3D; 3.32 ± 0.73, p=0.98) in D2-MSNs. 
These data thus far demonstrate that dopamine D1 receptor signaling at synapses 
on D1-MSNs is necessary for cocaine-induced reversal of AMPAR signaling. Next, we 
asked whether dopamine receptor stimulation is sufficient to induce depotentiation. 
Application of the D1 receptor agonist SKF 81297 (20 µM) produced a reduction in 
mEPSC amplitude (figure 4.3C; 11.47 ± 0.52, 6 cells/3 animals; p=0.048) and frequency 
(figure 4.3C; 3.58 ± 0.68; p=0.0018) in D1-MSNs, while the D2 receptor agonist 
quinpirole (10 µM) had no effect on mEPSC amplitude (figure 4.3D; 10.17 ± 0.84, 5 
cells/2 animals; p=0.99). However, application of quinpirole produced very low mEPSC 
frequency in D2-MSNs (figure 4.3D; 1.55 ± 0.25). Likely due to the high variability of 
sample observations in this dataset, this finding was not significantly different from 
mEPSC frequency in saline pre-treated animals (Sal) or cocaine pre-treated animals 
before challenge (Coc); however, it did differ significantly from cells treated with ex vivo 
cocaine (Coc-coc).  
In a limited set of control experiments, application of the D1 antagonist 
SCH23390 during ex vivo cocaine re-exposure did not alter synaptic transmission in D2-
MSNs from animals in cocaine abstinence [amplitude: 10.85 ± 0.14, p=0.6760; 
frequency: 3.43 ± 0.56, p=0.995; 5 cells/4 animals; data not shown], and similarly, the D1 
agonist SKF81297 did not alter transmission in D2-MSNs compared to slices from 
animals in abstinence (amplitude: 9.68 ± 0.76, p>0.99; frequency: 4.45 ± 0.80, p=0.9620; 
data not shown). Similarly, the D2 antagonist sulpiride in the presence of cocaine did not 
  80 
modify synaptic strength in D1-MSNs during abstinence (amplitude: 13.48 ± 0.36, 
p=0.9483; frequency: 4.20 ± 0.49, p=0.1163; 3 cells/1 animal, data not shown), and 
application of the D2 agonist quinpirole furthermore did not alter D1-MSN transmission 
compared to slices from animals in abstinence (amplitude: 16.42 ± 2.80, p=0.8405; 
frequency: 5.80 ± 2.10, p=0.6504; 2 cells/1 animal, data not shown). These findings 
indicate no evidence for cross-modulation of DA receptor signaling in specific MSN cell 
types, with no effect of D2 receptor modulation observed in MSNs expressing D1 
receptors, and similarly no effect of D1 modulation in D2-expressing MSNs. Thus, the 
ability of a particular DA receptor type to modulate synaptic transmission is specific to 
MSNs expressing that specific receptor type. 
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Figure 4.3. Cell type-specific bidirectional plasticity in the NAc shell is differentially 
modulated by dopamine receptors. (A,B) Representative mEPSC traces from NAc shell D1-
MSNs and D2-MSNs. (B) Mean mEPSC amplitude and frequency in NAc shell D1-MSNs from 
saline + no challenge (Sal), cocaine + no challenge (Coc), cocaine + ex vivo cocaine challenge 
(Coc-coc), cocaine + SCH23390/coc (Coc-SCH-Coc), and cocaine + SKF81297 (Coc-SKF). (C) 
Mean mEPSC amplitude and frequency in NAc shell D2-MSNs from saline + no challenge (Sal), 
cocaine + no challenge (Coc), cocaine + ex vivo cocaine challenge (Coc-coc), cocaine + 
sulpiride/coc (Coc-SLP-Coc), and cocaine + quinpirole (Coc-Quin). (E,G) Cumulative 
probability distributions of mEPSC amplitude and inter-event interval in D1-MSNs from cocaine 
+ no challenge (Coc), cocaine + ex vivo cocaine challenge (Coc-coc), cocaine + SCH23390/coc 
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(Coc-SCH-Coc), and cocaine + SKF81297 (Coc-SKF). (F,H) Cumulative probability 
distributions of mEPSC amplitude and inter-event interval in D2-MSNs from cocaine + no 
challenge (Coc), cocaine + ex vivo cocaine challenge (Coc-coc), cocaine + sulpiride/coc (Coc-
SLP-Coc), and cocaine + quinpirole (Coc-Quin). All data are presented as mean ± SEM. * p<0.05 
vs. Coc, ** p≤0.01 vs. Coc, *** p≤0.001 vs Coc; # p<0.05 vs. Coc-SCH-Coc; ## p<0.01 vs. Coc-
SCH-Coc; ++p<0.001 vs. Coc-coc. 
 
  
Dopamine and endocannabinoid modulation of cocaine-induced AMPAR plasticity in the 
NAc shell is cell type-specific. 
In addition to the known role of dopamine in modulating excitatory synaptic 
plasticity in the striatum, endogenous cannabinoids (eCBs) prominently shape synaptic 
activity and plasticity in the striatum (Gerdeman et al., 2002; Robbe et al., 2002). 
Previous studies indicate that eCB-mediated synaptic plasticity requires D2 receptor 
activation and furthermore occurs selectively in D2-expressing MSNs of the striatum. 
However, little is known regarding how cocaine experience alters neuromodulatory 
signaling at excitatory synapses on specific MSN cell subtypes. To investigate this, we 
first examined the role of CB1 signaling in synaptic depotentiation within specific MSN 
cell sub-types. In D1-MSNs, bath application of the CB1 receptor antagonist SR141716A 
(1 µM) produced a modest blockade of the depotentiation of mEPSC amplitude (figure 
4.4C; 12.6 ± 0.52, 6 cells/3 animals; F5,35=7.891, p<0.0001) and a more robust blockade 
of the reduction in mEPSC frequency (figure 4.4C; 5.51 ± 0.84; F5,34=7.76, p<0.0001). 
In D2-MSNs, SR141716A had no effect on mEPSC amplitude (figure 4.4D; 9.82 ± 0.40, 
7 cells/4 animals; F5,33=0.46, p=0.80) or frequency (figure 4.4D; 3.09 ± 0.66; p=0.96).  
Several lines of evidence suggest that in the striatum, activation of dopamine 
receptors facilitates eCB production that participates in modifying synaptic efficacy. A 
number of studies have demonstrated that under basal (non-drug) conditions, activation 
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of dopamine D2 receptors in the striatum (dorsal and ventral) is sufficient to promote 
increased production of eCBs (Centonze et al., 2004; Giuffrida et al., 1999; Wang et al., 
2006). However, it is unknown whether these mechanisms play a role in reducing 
synaptic strength following cocaine exposure. Therefore, we asked whether DA receptor-
mediated depotentiation of AMPAR signaling requires serial activation of CB1 receptors 
as well. Pre-incubation of slices in the CB1 receptor antagonist SR141716A prior to bath 
application of the D1 receptor agonist SKF 81297 (20 µM) in D1-MSNs produced 
depotentiation of mEPSC amplitude (figure 4.4C: 10.33 ± 0.52, 6 cells/4 animals; 
p=0.002) but blocked the reduction of mEPSC frequency (figure 4.4C; 5.39 ± 1.28, 
p=0.049). In D2-MSNs, mEPSC amplitude was unaffected by exposure to the CB1 
antagonist in the presence of the D2 receptor agonist quinpirole (figure 4.4D; 10.32 ± 
0.82, 6 cells/3 animals; p=0.8009); however, while mEPSC frequency was not 
significantly changed relative to saline pre-treated animals (Sal) or cocaine pre-treated 
animals (Coc), bath exposure to the CB1 antagonist during incubation in the D2 agonist 
produced a visible elevation in frequency relative to the quinpirole-mediated suppression 
in D2-MSNs (figure 4.4D; 4.56 ± 0.80; p=0.0581). Nevertheless, this tendency toward an 
increase in frequency was not significantly different compared to other groups.  
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Figure 4.4. Dopamine and endocannabinoid modulation of cocaine-induced AMPAR 
plasticity in the NAc shell is cell type-specific. (A,B) Representative mEPSC traces from NAc 
shell D1-MSNs and D2-MSNs. (B) Mean mEPSC amplitude and frequency in NAc shell D1-
MSNs from saline + no challenge (Sal), cocaine + no challenge (Coc), cocaine + ex vivo cocaine 
challenge (Coc-coc), cocaine + SR141716A/coc (Coc-SR-Coc), cocaine + SKF81297 (Coc-SKF), 
and cocaine + SR141716A/SKF81297 (Coc-SR-SKF). (C) Mean mEPSC amplitude and 
frequency in NAc shell D2-MSNs from saline + no challenge (Sal), cocaine + no challenge (Coc), 
cocaine + ex vivo cocaine challenge (Coc-coc), cocaine + SR141716A/coc (Coc-SR-Coc), 
cocaine + quinpirole (Coc-Quin), and cocaine + SR141716A/quinpirole (Coc-SR-Quin). (E,G) 
Cumulative probability distributions of mEPSC amplitude and inter-event interval in D1-MSNs 
from cocaine + no challenge (Coc), cocaine + ex vivo cocaine challenge (Coc-coc), cocaine + 
SR141716A/coc (Coc-SR-Coc), cocaine + SKF81297 (Coc-SKF), and cocaine + 
SR141716A/SKF81297 (Coc-SR-SKF). (F,H) Cumulative probability distributions of mEPSC 
amplitude and inter-event interval in D2-MSNs from cocaine + no challenge (Coc), cocaine + ex 
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vivo cocaine challenge (Coc-coc), cocaine + SR141716A/coc (Coc-SR-Coc), cocaine + 
quinpirole (Coc-Quin), and cocaine + SR141716A/quinpirole (Coc-SR-Quin). All data are 
presented as mean ± SEM. * p<0.05 vs. Coc, ** p≤0.01 vs. Coc, *** p≤0.001 vs Coc, **** 
p<0.0001 vs. Coc; ++p<0.01 vs. Coc-Coc. 
 
 
Discussion 
 Within the striatum, repeated cocaine exposure causes enduring adaptations in 
glutamatergic synaptic strength in NAc MSNs. To date, substantial evidence 
demonstrates that cocaine appears to selectively alter excitatory synaptic transmission at 
synapses on D1-expressing MSNs (Kim et al., 2011; Pascoli et al., 2014, 2011; Terrier et 
al., 2016), neurons of the striatal “direct pathway” that have been shown to critically 
mediate reward-related learning and approach behavior (Lobo and Nestler, 2011). 
However, it is currently unknown whether the reversal of enhanced AMPAR synaptic 
transmission induced by cocaine re-exposure is mediated by specific MSN cell types in 
the NAc shell. One would predict that synaptic adaptations occurring selectively on D1-
MSNs would likely be reversed on D1-MSNs as well; yet, it is possible that 
depotentiation of synaptic strength could reflect a reduction in basal synaptic 
transmission in D2-MSNs. Given the opposing roles these cell types appear to exert on 
reward-seeking behavior, such a reduction in signaling at D2-MSNs might produce a 
subsequent shift in excitatory drive toward D1-MSN activation, promoting renewed drug-
seeking behavior.  
 Our findings, however, appeared to confirm our former hypothesis: similar to 
previous studies, abstinence from repeated cocaine selectively enhanced AMPAR 
synaptic transmission at D1-MSN synapses in the NAc shell, while cocaine re-exposure 
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ex vivo reversed enhanced signaling at D1-MSNs. In D2-MSNs, repeated cocaine 
predictably had no effect on mEPSC amplitude, a measure generally considered to reflect 
the number and/or function of post-synaptic AMPARs. However, ex vivo cocaine 
challenge produced a noticeable elevation in the frequency of mEPSC events in D2-
MSN, hinting at increased glutamate release probability at synapses on D2-MSNs.  
 Studies examining the expression of behavioral sensitization to cocaine (Henry et 
al., 1998; Mattingly et al., 1994) and reinstatement of cocaine seeking behavior following 
a period of abstinence or extinction (Schmidt et al., 2006; Anderson et al., 2006, 2003)  
commonly demonstrate a requirement of both dopamine D1 and D2 receptor signaling in 
the NAc, indicating that cooperative action of both of these receptor types in the NAc 
mediates the response to cocaine re-exposure. However, D1 receptor activation has been 
shown to specifically modulate alterations in NAc excitatory synaptic transmission 
induced by cocaine experience, while D2 signaling appears to have a minimal effect on 
synaptic transmission. For example, stimulation of D1 receptors during late abstinence 
from cocaine (3-4 weeks) is sufficient to normalize enhanced AMPAR synaptic strength 
in the NAc shell (Ortinski et al., 2012). Here, we observed that D1 receptor activity is 
both necessary and sufficient to reverse potentiated mEPSC amplitude and frequency in 
NAc shell D1-MSNs only, suggesting that synaptic depotentiation involves engagement 
of specific D1 receptors on specific D1-expressing MSNs. However, while D2 activation 
had no effect on mEPSC amplitude in D2-MSNs, we observed more complex effects on 
mEPSC frequency. Although statistically insignificant perhaps due to high variability in 
our sample observations, we found that a D2 receptor antagonist applied during cocaine 
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re-exposure appeared to rescue the increase in frequency induced by ex vivo cocaine in 
D2-MSNs, additionally reducing the variability of responses in this cell type. While this 
trend was apparent but not significant, further research is needed to determine how D2 
signaling modulates augmented glutamate release properties following cocaine re-
exposure. Additionally, application of the D2 agonist quinpirole was sufficient to 
suppress mEPSC frequency below basal levels, a finding which may reflect activation of 
pre-synaptic D2 autoreceptors that suppress excitatory signaling in the NAc (André et al., 
2010; Wang et al., 2012).  
These data present a rather complex and incomplete picture of how dopamine 
receptor activation differentially alters cocaine-mediated synaptic plasticity in the NAc. 
However, this study suggests that distinct receptor subtypes mediate very different forms 
of plasticity at NAc MSN synapses following cocaine exposure. D1 signaling appears to 
modify post-synaptic AMPAR signaling due to its ability to independently reverse and 
induce synaptic depotentiation of AMPAR mEPSC amplitude and frequency, while D2 
activity modulates alterations in mEPSC frequency induced by cocaine exposure, 
indicating complex modulation of pre-synaptic glutamate release properties.  
In the NAc, endocannabinoid signaling potently regulates excitatory synaptic 
transmission, mediating several forms of synaptic depression at glutamatergic synapses 
on NAc MSNs (Zlebnik and Cheer, 2016). Furthermore, it has been suggested that eCB-
mediated synaptic depression requires activation of post-synaptic D2 receptors, occurring 
preferentially in D2-MSNs (Grueter et al., 2010; Kreitzer and Malenka, 2007; Shen et al., 
2008). However, this has been challenged by studies demonstrating that eCB signaling is 
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capable of altering excitatory signaling at both D1- and D2-MSN synapses (Bagetta et al., 
2011; Wang et al., 2006). A potential explanation for the D2 requirement in eCB 
signaling is that D2 receptor activation facilitates eCB production in the striatum 
(Centonze et al., 2004; Giuffrida et al., 1999; Patel et al., 2003; Wang et al., 2006), and 
therefore may be sufficient to reduce synaptic strength at activated synapses alone or in 
combination with group I mGluRs, which mobilize eCBs through Gq-mediated signaling.  
Here, we found that the CB1 receptor antagonist SR141716A prevented the 
reduction of mEPSC amplitude and frequency induced by cocaine re-exposure in D1-
MSNs. Conversely, CB1 antagonism had no effect on mEPSC amplitude in D2-MSNs 
but, similar to sulpiride, appeared to reverse the elevated mEPSC frequency following 
cocaine challenge ex vivo. We therefore observed that CB1 receptor activation is 
necessary for reducing synaptic strength at both D1- and D2-MSN synapses in the NAc. 
This finding is in line with recent reports contesting the notion that eCB-mediated 
synaptic plasticity occurs selectively at D2-MSNs. Instead, this mechanism may undergo 
complex modulation by other synaptic and cellular signaling factors. For example, 
several studies have shown that the D2 receptor dependence of striatal LTD reflects 
suppression of muscarinic receptor 1 (M1) signaling due to activation of D2 receptors on 
cholinergic interneurons, a requirement for induction of LTD at both D1- and D2-MSN 
synapses (Tozzi et al, 2011; Wang et al, 2006), indicating a means by which D2 receptor 
activity could modulate glutamatergic signaling at both synapse types. 
Emerging evidence indicates that eCB and dopamine signaling mechanisms 
interact to modulate synaptic strength in striatal circuits (Garcia et al. 2016). To test 
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whether DA-mediated depotentiation of synaptic strength requires CB1 signaling, we 
blocked CB1 receptors while activating DA receptors. We found that the D1 agonist 
SKF81297 was sufficient to depotentiate mEPSC amplitude in D1-MSNs, without 
requiring coincident CB1 activity. However, the D1 agonist was not sufficient to reverse 
the potentiated mEPSC frequency, indicating that CB1 signaling downstream of D1 
receptors may be necessary to dampen glutamate release from terminals on D1-MSNs. 
Similarly, in D2-MSNs, CB1 activation was necessary for D2 receptor-mediated 
suppression of mEPSC frequency, indicating that serial activation of dopamine and eCBs 
may be important for modulating release properties at the terminal. Potentially due to the 
relatively high variability of observations in this dataset, these findings in D2-MSNs were 
not statistically significant, but produced a visible trend. Given that different signaling 
mechanisms mediate plasticity at excitatory synapses on D1- vs. D2-MSNs (Lüscher and 
Huber, 2010), understanding how cocaine exposure drives aberrant plasticity in the NAc 
will require a deeper investigation of the mechanisms underlying MSN cell type-specific 
plasticity. These findings indicate complex modulation of pre-synaptic plasticity by 
dopamine and eCB signaling mechanisms. 
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Discussion and Conclusion 
 
 A wealth of literature has established that addiction is a pathological disorder 
characterized by progressive alterations in brain functions mediating reward. Drugs of 
abuse gradually alter brain circuits important for learning and adaptation, and drive a 
transition toward drug-seeking behavior. Thus, addiction may be viewed as a disorder of 
staged neuroplasticity, engaging mechanisms that naturally promote behavioral 
adaptation and plasticity, and driving maladaptive learning that motivates persistent drug-
seeking (Kalivas and O’Brien, 2007; Lüscher, 2013).  
 The purpose of this work was to identify and characterize endogenous 
mechanisms of plasticity in the nucleus accumbens that are engaged by drug experience 
and participate in modifying synaptic function. Here, I focused on a number of 
neuromodulatory signaling mechanisms that are capable of finely adjusting excitatory 
synaptic strength in the NAc. As reviewed throughout this work, alterations in 
glutamatergic transmission at corticolimbic afferents to the nucleus accumbens is an 
important factor driving the persistence of drug-seeking behavior following chronic 
psychostimulant use. Coupled with this, long-term cocaine experience increases the 
sensitivity of MSNs to respond to glutamate input through enhanced synaptic strength 
mediated by upregulated AMPARs signaling. Subsequent drug re-exposure, cues 
associated with drug use, or stress—all common triggers for relapse—are capable of 
rapidly depotentiating enhanced AMPAR transmission. Understanding the 
neurobiological mechanisms underpinning this synaptic adaptation viewed across 
common relapse-related stimuli is the focus of my work here. 
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 These studies broadly demonstrated that dopamine, endocannabinoids, and 
metabotropic glutamate receptors (Group I mGluRs) can have diverse effects on 
AMPAR-mediated synaptic function in the NAc depending on previous cocaine 
experience. Both dopamine and endocannabinoids, critical modulators of NAc synaptic 
plasticity and addiction-related behavior, contribute to cocaine-induced depotentiation of 
AMPAR synaptic strength, indicating that cocaine re-exposure engages multiple 
endogenous signaling pathways in the NAc that cooperate in modifying excitatory 
synaptic strength. Furthermore, we demonstrated that NAc synaptic depotentiation is 
rapidly induced but constrained to a relatively short time window of several (1-4) days, 
indicating that synapses undergo dynamic shifts in efficacy following subsequent drug re-
exposures, but ultimately recover to their previously-potentiated synaptic states 
established by repeated, chronic drug experience. Understanding the mechanisms 
underlying this rapid form of plasticity could provide insight into the neurobiological 
correlates supporting persistent drug-seeking behavior, with the goal of prolonging 
abstinence by reversing or somehow compensating for these pernicious neuroadaptations. 
 Additionally, this work sought to characterize cellular signaling mechanisms at 
synapses on D1- and D2-MSNs, two distinct populations that mediate divergent 
responses to addicting drugs as well as differential plasticity following cocaine exposure 
(Smith et al., 2013). Similar to previous studies, we observed that repeated cocaine 
selectively potentiated synapses on D1-MSNs, while having minimal effects on D2-
MSNs. Interestingly, we were more likely to find alterations in post-synaptic signaling 
mechanisms (i.e. mEPSC amplitude) at D1-MSN synapses, while presumed pre-synaptic 
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mechanisms of transmitter release (as revealed by changes in mEPSC frequency) 
appeared to be altered in a complex way at D2-MSNs following cocaine re-exposure. We 
found that in addition to the ability of D1 receptors to depotentiate AMPAR signaling at 
D1-MSN synapses, dopamine receptors on both cell subtypes may promote CB1 
activation in a serial manner, given that CB1 receptor activation was necessary for the 
dopamine receptor-induced suppression of mEPSC frequency. 
 
Figure 5. Summary schematic of cellular signaling mechanisms altered  
by cocaine experience. Distinct mechanisms promote plasticity at D1- vs. D2-MSN synapses in 
the NAc. We found that activity of mGluR5 receptors is necessary for inducing depotentiation of 
augmented post-synaptic AMPAR-mediated transmission during abstinence from cocaine, 
potentially by promoting internalization of AMPARs. In specific MSN cell types, we identified 
that D1 receptors are capable of altering AMPAR-signaling at synapses on D1-MSNs, likely also 
reflecting alterations in AMPAR trafficking mechanisms in these cell types. Additionally, CB1 
signaling at both D1- and D2-MSN synapses was necessary for the suppression of mEPSC 
frequency induced by cocaine re-exposure, suggesting that eCB-mediated reductions in synaptic 
strength do not necessarily occur selectively at D2-MSN synapses. Furthermore, we found that 
activation of CB1 receptors downstream of dopamine receptor activity mediates the dopamine-
induced reduction in mEPSC frequency at both MSN cell types. Thus, cellular signaling factors 
(i.e. mGluR5 and DA receptors) activated by cocaine re-exposure may converge on common 
factors including eCB signaling mechanisms to promote a reduction in synaptic strength. 
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Throughout these studies, we consistently observed complex alterations in presumed measures of 
pre-synaptic plasticity (i.e. mEPSC frequency), indicating that cocaine re-exposure may have 
complex effects on terminal release properties by potentially engaging receptors expressed on 
glutamatergic afferents that regulate release, including CB1 and D2 receptors. 
 
 
 Alterations in glutamatergic synaptic transmission induced by experience with 
cocaine may therefore profoundly alter the responsiveness of MSNs to future stimulation 
by dopamine, modifying the capacity of dopamine to effectively gate activity and 
plasticity at glutamatergic synapses. Additionally, changes in dopamine receptor 
expression and signaling mechanisms (Anderson and Pierce, 2005) may modify how 
dopamine and glutamate receptor signaling mechanisms converge and interact at an 
intracellular level. Furthermore, mGluR1/5 and eCBs may additionally adjust MSN 
responsiveness to alterations in glutamatergic signaling induced by cocaine experience. 
While future work is needed to characterize how particular inputs impinging on the NAc 
as well as specific neural ensembles within the NAc differentially mediate plasticity, this 
work begins to characterize how cocaine experience alters common signaling factors that 
ultimately drive addiction-related behavior.  
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